{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 922209, "items": [{"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:14:16Z", "timestamp": 1576797256398}, "reference-count": 28, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2013, 2, 10]]}, "abstract": "<jats:sec><jats:title>Purpose</jats:title><jats:p> Apart from localized gastric disease, there is no consensus on standard initial treatment of mucosa-associated lymphoid tissue lymphoma. The IELSG-19 study (Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab Versus Rituximab in MALT Lymphoma) was launched to compare chlorambucil alone versus chlorambucil plus rituximab in patients not previously given systemic anticancer therapy. </jats:p></jats:sec><jats:sec><jats:title>Patients and Methods</jats:title><jats:p> Patients not responding to or not suitable for local therapy were eligible. In arm A, chlorambucil was given daily 6 mg/m<jats:sup>2</jats:sup> orally (PO) for 6 weeks. Responding patients and those with stable disease continued to be given daily chlorambucil 6 mg/m<jats:sup>2</jats:sup> PO for 14 consecutive days every 28 days for four cycles. In arm B, intravenous rituximab 375 mg/m<jats:sup>2</jats:sup> per day was added on days 1, 8, 15, 22, 56, 84, 112, and 140. After completion of the planned accrual, the protocol was amended to introduce a third arm with rituximab alone. We report the planned final analysis of the first two arms (113 patients in arm A and 114 in arm B). </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> At a median follow-up of 62 months, the 5-year event-free survival (EFS) was significantly better for the patients treated in arm B (68% v 50%; P = .002) who, despite similar overall response rates (90% v 87%), achieved a higher complete remission rate (78% v 65%; P = .025). Progression-free survival was also improved but it did not reach statistical significance (P = .057). Five-year overall survival (OS) was 89% in both arms. Both treatments were well tolerated without unexpected toxicities. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> Both treatments were active; the better response rate and EFS obtained with the addition of rituximab did not translate into improved OS. </jats:p></jats:sec>", "DOI": "10.1200/jco.2011.40.6272", "type": "journal-article", "created": {"date-parts": [[2013, 1, 8]], "date-time": "2013-01-08T22:42:27Z", "timestamp": 1357684947000}, "page": "565-572", "source": "Crossref", "is-referenced-by-count": 133, "title": ["Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study"], "prefix": "10.1200", "volume": "31", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Annarita", "family": "Conconi", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Daniele", "family": "Laszlo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Armando", "family": "L\u00f3pez-Guillermo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Reda", "family": "Bouabdallah", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Bertrand", "family": "Coiffier", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Catherine", "family": "Sebban", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Fabrice", "family": "Jardin", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Umberto", "family": "Vitolo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Franck", "family": "Morschhauser", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Stefano A.", "family": "Pileri", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Christiane", "family": "Copie-Bergman", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Elias", "family": "Campo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Andrew", "family": "Jack", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Irene", "family": "Floriani", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Peter", "family": "Johnson", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Maurizio", "family": "Martelli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}, {"given": "Catherine", "family": "Thieblemont", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Annarita Conconi, Amedeo Avogadro University of Eastern Piedmont, Novara; Daniele Laszlo and Giovanni Martinelli, European Institute of Oncology; Irene Floriani, Mario Negri Pharmacological Research Institute, Milan; Umberto Vitolo, S. Giovanni Battista Hospital, Torino; Stefano A. Pileri, University of Bologna, Bologna; Maurizio Martelli, University \u201cLa Sapienza,\u201d Rome, Italy; Armando L\u00f3pez-Guillermo..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.40.6272", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:17:54Z", "timestamp": 1574885874000}, "score": 73.47098, "issued": {"date-parts": [[2013, 2, 10]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2013, 2, 10]]}, "issue": "5"}, "alternative-id": ["10.1200/JCO.2011.40.6272"], "URL": "http://dx.doi.org/10.1200/jco.2011.40.6272", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T18:13:15Z", "timestamp": 1575223995030}, "publisher-location": "Totowa, NJ", "reference-count": 128, "publisher": "Humana Press", "isbn-type": [{"value": "9781627034074", "type": "print"}, {"value": "9781627034081", "type": "electronic"}], "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2013, 1, 1]], "date-time": "2013-01-01T00:00:00Z", "timestamp": 1356998400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": ["link.springer.com"], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013]]}, "DOI": "10.1007/978-1-62703-408-1_6", "type": "book-chapter", "created": {"date-parts": [[2013, 5, 16]], "date-time": "2013-05-16T19:56:46Z", "timestamp": 1368734206000}, "page": "111-126", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MALT Lymphoma (Extranodal Marginal Zone B-Cell Lymphoma)"], "prefix": "10.1007", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": []}, {"given": "Francesco", "family": "Bertoni", "sequence": "additional", "affiliation": []}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2013, 4, 15]]}, "reference": [{"key": "6_CR00061", "author": "PI Isaacson", "first-page": "214", "year": "2008", "unstructured": "Isaacson PI, Chott A, Nakamura H, Muller-Hermelink HK, Harris NL, Swerdlow SH, et al. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, editors. World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 214\u20137.", "volume-title": "World Health Organization Classification of Tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues"}, {"issue": "19", "key": "6_CR00062", "doi-asserted-by": "publisher", "first-page": "5019", "DOI": "10.1182/blood-2011-01-293050", "volume": "117", "author": "E Campo", "year": "2011", "unstructured": "Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019\u201332.", "journal-title": "Blood"}, {"issue": "11", "key": "6_CR00063", "first-page": "3909", "volume": "89", "author": "A clinical evaluation of the International Lymphoma Study", "year": "1997", "unstructured": "A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood. 1997;89(11):3909\u201318.", "journal-title": "Blood"}, {"issue": "6", "key": "6_CR00064", "doi-asserted-by": "publisher", "first-page": "569", "DOI": "10.1016/0046-8177(93)90233-7", "volume": "24", "author": "PG Isaacson", "year": "1993", "unstructured": "Isaacson PG, Spencer J. Is gastric lymphoma an infectious disease? Hum Pathol. 1993;24(6):569\u201370.", "journal-title": "Hum Pathol"}, {"issue": "8", "key": "6_CR00065", "doi-asserted-by": "publisher", "first-page": "644", "DOI": "10.1038/nrc1409", "volume": "4", "author": "PG Isaacson", "year": "2004", "unstructured": "Isaacson PG, Du MQ. MALT lymphoma: from morphology to molecules. Nat Rev Cancer. 2004;4(8):644\u201353.", "journal-title": "Nat Rev Cancer"}, {"issue": "2", "key": "6_CR00066", "first-page": "410", "volume": "96", "author": "E Zucca", "year": "2000", "unstructured": "Zucca E, Bertoni F, Roggero E, Cavalli F. The gastric marginal zone B-cell lymphoma of MALT type. Blood. 2000;96(2):410\u20139.", "journal-title": "Blood"}, {"key": "6_CR00067", "doi-asserted-by": "publisher", "first-page": "97", "DOI": "10.1016/S1470-2045(02)00651-4", "volume": "3", "author": "MQ Du", "year": "2002", "unstructured": "Du MQ, Isaacson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002;3:97\u2013104.", "journal-title": "Lancet Oncol"}, {"issue": "8776", "key": "6_CR00068", "doi-asserted-by": "publisher", "first-page": "1175", "DOI": "10.1016/0140-6736(91)92035-Z", "volume": "338", "author": "AC Wotherspoon", "year": "1991", "unstructured": "Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338(8776):1175\u20136.", "journal-title": "Lancet"}, {"issue": "1", "key": "6_CR00069", "doi-asserted-by": "publisher", "first-page": "3", "DOI": "10.1002/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P", "volume": "79", "author": "S Nakamura", "year": "1997", "unstructured": "Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer. 1997;79(1):3\u201311.", "journal-title": "Cancer"}, {"issue": "8797", "key": "6_CR000610", "doi-asserted-by": "publisher", "first-page": "834", "DOI": "10.1016/0140-6736(92)90280-G", "volume": "339", "author": "C Doglioni", "year": "1992", "unstructured": "Doglioni C, Wotherspoon AC, Moschini A, De Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet. 1992;339(8797):834\u20135.", "journal-title": "Lancet"}, {"issue": "14", "key": "6_CR000611", "doi-asserted-by": "publisher", "first-page": "5740", "DOI": "10.1158/0008-5472.CAN-09-4690", "volume": "70", "author": "WC Lin", "year": "2010", "unstructured": "Lin WC, Tsai HF, Kuo SH, et al. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res. 2010;70(14):5740\u20138.", "journal-title": "Cancer Res"}, {"issue": "2", "key": "6_CR000612", "doi-asserted-by": "publisher", "first-page": "263", "DOI": "10.1016/S0046-8177(00)80233-6", "volume": "31", "author": "E Roggero", "year": "2000", "unstructured": "Roggero E, Zucca E, Mainetti C, et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol. 2000;31(2):263\u20138.", "journal-title": "Hum Pathol"}, {"issue": "11", "key": "6_CR000613", "doi-asserted-by": "publisher", "first-page": "658", "DOI": "10.1038/nrclinonc.2009.147", "volume": "6", "author": "AJ Ferreri", "year": "2009", "unstructured": "Ferreri AJ, Dolcetti R, Magnino S, Doglioni C, Ponzoni M. Chlamydial infection: the link with ocular adnexal lymphomas. Nat Rev Clin Oncol. 2009;6(11):658\u201369.", "journal-title": "Nat Rev Clin Oncol"}, {"issue": "1", "key": "6_CR000614", "doi-asserted-by": "publisher", "first-page": "107", "DOI": "10.1002/cncr.11893", "volume": "100", "author": "L Arcaini", "year": "2004", "unstructured": "Arcaini L, Paulli M, Boveri E, et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer. 2004;100(1):107\u201315.", "journal-title": "Cancer"}, {"issue": "2", "key": "6_CR000615", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1056/NEJMoa013376", "volume": "347", "author": "O Hermine", "year": "2002", "unstructured": "Hermine O, Lefrere F, Bronowicki JP, et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med. 2002;347(2):89\u201394.", "journal-title": "N Engl J Med"}, {"issue": "8", "key": "6_CR000616", "doi-asserted-by": "publisher", "first-page": "586", "DOI": "10.1093/jnci/djh102", "volume": "96", "author": "AJ Ferreri", "year": "2004", "unstructured": "Ferreri AJ, Guidoboni M, Ponzoni M, et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst. 2004;96(8):586\u201394.", "journal-title": "J Natl Cancer Inst"}, {"issue": "8", "key": "6_CR000617", "doi-asserted-by": "publisher", "first-page": "4029", "DOI": "10.1182/blood-2007-10-119974", "volume": "111", "author": "K Ekstrom Smedby", "year": "2008", "unstructured": "Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood. 2008;111(8):4029\u201338.", "journal-title": "Blood"}, {"issue": "6", "key": "6_CR000618", "doi-asserted-by": "publisher", "first-page": "2274", "DOI": "10.1182/blood-2004-07-2755", "volume": "105", "author": "T Al-Saleem", "year": "2005", "unstructured": "Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105(6):2274\u201380.", "journal-title": "Blood"}, {"issue": "3", "key": "6_CR000619", "doi-asserted-by": "publisher", "first-page": "239", "DOI": "10.1056/NEJMoa031887", "volume": "350", "author": "M Lecuit", "year": "2004", "unstructured": "Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med. 2004;350(3):239\u201348.", "journal-title": "N Engl J Med"}, {"issue": "4", "key": "6_CR000620", "doi-asserted-by": "publisher", "first-page": "488", "DOI": "10.1002/1096-9896(2000)9999:9999<::AID-PATH727>3.0.CO;2-J", "volume": "192", "author": "MQ Du", "year": "2000", "unstructured": "Du MQ, Diss TC, Dogan A, et al. Clone-specific PCR reveals wide dissemination of gastric MALT lymphoma to the gastric mucosa. J Pathol. 2000;192(4):488\u201393.", "journal-title": "J Pathol"}, {"issue": "5", "key": "6_CR000621", "doi-asserted-by": "publisher", "first-page": "413", "DOI": "10.1111/j.1365-2559.1995.tb00248.x", "volume": "26", "author": "M Fraga", "year": "1995", "unstructured": "Fraga M, Lloret E, Sanchez-Verde L, et al. Mucosal mantle cell (centrocytic) lymphomas. Histopathology. 1995;26(5):413\u201322.", "journal-title": "Histopathology"}, {"issue": "6", "key": "6_CR000622", "doi-asserted-by": "publisher", "first-page": "614", "DOI": "10.1007/s00428-002-0670-5", "volume": "441", "author": "A Tzankov", "year": "2002", "unstructured": "Tzankov A, Hittmair A, Muller-Hermelink HK, Rudiger T, Dirnhofer S. Primary gastric follicular lymphoma with parafollicular monocytoid B-cells and lymphoepithelial lesions, mimicking extranodal marginal zone lymphoma of MALT. Virchows Arch. 2002;441(6):614\u20137.", "journal-title": "Virchows Arch"}, {"issue": "4", "key": "6_CR000623", "first-page": "260", "volume": "13", "author": "JK Chan", "year": "1996", "unstructured": "Chan JK. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol. 1996;13(4):260\u201396.", "journal-title": "Semin Diagn Pathol"}, {"key": "6_CR000624", "doi-asserted-by": "publisher", "first-page": "433", "DOI": "10.1196/annals.1422.046", "volume": "1108", "author": "R Jonsson", "year": "2007", "unstructured": "Jonsson R, Bolstad AI, Brokstad KA, Brun JG. Sjogren\u2019s syndrome\u2014a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci. 2007;1108:433\u201347.", "journal-title": "Ann N Y Acad Sci"}, {"issue": "4", "key": "6_CR000625", "doi-asserted-by": "publisher", "first-page": "830", "DOI": "10.1046/j.1365-2141.1997.1392954.x", "volume": "97", "author": "F Bertoni", "year": "1997", "unstructured": "Bertoni F, Cazzaniga G, Bosshard G, et al. Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol. 1997;97(4):830\u20136.", "journal-title": "Br J Haematol"}, {"issue": "7", "key": "6_CR000626", "first-page": "1190", "volume": "10", "author": "M Du", "year": "1996", "unstructured": "Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996;10(7):1190\u20137.", "journal-title": "Leukemia"}, {"issue": "3", "key": "6_CR000627", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1182/blood-2009-06-228015", "volume": "115", "author": "VJ Craig", "year": "2010", "unstructured": "Craig VJ, Arnold I, Gerke C, et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood. 2010;115(3):581\u201391.", "journal-title": "Blood"}, {"issue": "2", "key": "6_CR000628", "doi-asserted-by": "publisher", "first-page": "247", "DOI": "10.1038/sj.leu.2400908", "volume": "12", "author": "E Zucca", "year": "1998", "unstructured": "Zucca E, Bertoni F, Roggero E, et al. Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach. Leukemia. 1998;12(2):247\u20139.", "journal-title": "Leukemia"}, {"issue": "1", "key": "6_CR000629", "first-page": "285", "volume": "142", "author": "T Hussell", "year": "1993", "unstructured": "Hussell T, Isaacson PG, Crabtree JE, Dogan A, Spencer J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol. 1993;142(1):285\u201392.", "journal-title": "Am J Pathol"}, {"issue": "11", "key": "6_CR000630", "first-page": "3601", "volume": "93", "author": "J Dierlamm", "year": "1999", "unstructured": "Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa- associated lymphoid tissue lymphomas. Blood. 1999;93(11):3601\u20139.", "journal-title": "Blood"}, {"issue": "1", "key": "6_CR000631", "doi-asserted-by": "publisher", "first-page": "35", "DOI": "10.1016/S0092-8674(00)80957-5", "volume": "96", "author": "TG Willis", "year": "1999", "unstructured": "Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96(1):35\u201345.", "journal-title": "Cell"}, {"issue": "6", "key": "6_CR000632", "doi-asserted-by": "publisher", "first-page": "2335", "DOI": "10.1182/blood-2002-09-2963", "volume": "101", "author": "B Streubel", "year": "2002", "unstructured": "Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood. 2002;101(6):2335\u20139.", "journal-title": "Blood"}, {"issue": "4", "key": "6_CR000633", "doi-asserted-by": "crossref", "first-page": "652", "DOI": "10.1038/sj.leu.2403644", "volume": "19", "author": "B Streubel", "year": "2005", "unstructured": "Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia. 2005;19(4):652\u20138.", "journal-title": "Leukemia"}, {"issue": "12", "key": "6_CR000634", "doi-asserted-by": "publisher", "first-page": "1546", "DOI": "10.1097/01.pas.0000213275.60962.2a", "volume": "30", "author": "ED Remstein", "year": "2006", "unstructured": "Remstein ED, Dogan A, Einerson RR, et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am J Surg Pathol. 2006;30(12):1546\u201353.", "journal-title": "Am J Surg Pathol"}, {"issue": "1", "key": "6_CR000635", "first-page": "299", "volume": "87", "author": "J Dierlamm", "year": "1996", "unstructured": "Dierlamm J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood. 1996;87(1):299\u2013307.", "journal-title": "Blood"}, {"issue": "5", "key": "6_CR000636", "doi-asserted-by": "publisher", "first-page": "1595", "DOI": "10.1182/blood-2010-01-264275", "volume": "117", "author": "A Rinaldi", "year": "2011", "unstructured": "Rinaldi A, Mian M, Chigrinova E, et al. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood. 2011;117(5):1595\u2013604.", "journal-title": "Blood"}, {"issue": "11", "key": "6_CR000637", "doi-asserted-by": "publisher", "first-page": "2225", "DOI": "10.1038/sj.leu.2403122", "volume": "17", "author": "EM Murga Penas", "year": "2003", "unstructured": "Murga Penas EM, Hinz K, Roser K, et al. Translocations t(11;18)(q21;q21) and t(14;18)(q32;q21) are the main chromosomal abnormalities involving MLT/MALT1 in MALT lymphomas. Leukemia. 2003;17(11):2225\u20139.", "journal-title": "Leukemia"}, {"issue": "7", "key": "6_CR000638", "doi-asserted-by": "publisher", "first-page": "1064", "DOI": "10.3324/haematol.2011.040402", "volume": "96", "author": "I Kwee", "year": "2011", "unstructured": "Kwee I, Rancoita PM, Rinaldi A, et al. Genomic profiles of MALT lymphomas: variability across anatomic sites. Haematologica. 2011;96(7):1064\u20136.", "journal-title": "Haematologica"}, {"issue": "3", "key": "6_CR000639", "doi-asserted-by": "publisher", "first-page": "1012", "DOI": "10.1182/blood-2002-11-3502", "volume": "102", "author": "H Ye", "year": "2003", "unstructured": "Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood. 2003;102(3):1012\u20138.", "journal-title": "Blood"}, {"issue": "7", "key": "6_CR000640", "doi-asserted-by": "publisher", "first-page": "902", "DOI": "10.1038/modpathol.2008.74", "volume": "21", "author": "A Goatly", "year": "2008", "unstructured": "Goatly A, Bacon CM, Nakamura S, et al. FOXP1 abnormalities in lymphoma: translocation breakpoint mapping reveals insights into deregulated transcriptional control. Mod Pathol. 2008;21(7):902\u201311.", "journal-title": "Mod Pathol"}, {"key": "6_CR000641", "doi-asserted-by": "publisher", "first-page": "184", "DOI": "10.3324/haematol.2011.052639", "volume": "97", "author": "M Baens", "year": "2012", "unstructured": "Baens M, Finalet Ferreiro J, Tousseyn T, et al. t(X;14)(p11.4;q32.33) is recurrent in marginal zone lymphoma and upregulates GPR34. Haematologica. 2012;97:184\u20138.", "journal-title": "Haematologica"}, {"issue": "6016", "key": "6_CR000642", "doi-asserted-by": "publisher", "first-page": "468", "DOI": "10.1126/science.1198946", "volume": "331", "author": "S Rosebeck", "year": "2011", "unstructured": "Rosebeck S, Madden L, Jin X, et al. Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation. Science. 2011;331(6016):468\u201372.", "journal-title": "Science"}, {"issue": "10", "key": "6_CR000643", "doi-asserted-by": "publisher", "first-page": "3452", "DOI": "10.1158/0008-5472.CAN-03-3677", "volume": "64", "author": "Y Hosokawa", "year": "2004", "unstructured": "Hosokawa Y, Suzuki H, Suzuki Y, Takahashi R, Seto M. Antiapoptotic function of apoptosis inhibitor 2-MALT1 fusion protein involved in t(11;18)(q21;q21) mucosa-associated lymphoid tissue lymphoma. Cancer Res. 2004;64(10):3452\u20137.", "journal-title": "Cancer Res"}, {"issue": "5", "key": "6_CR000644", "doi-asserted-by": "publisher", "first-page": "1286", "DOI": "10.1053/gast.2002.33047", "volume": "122", "author": "H Liu", "year": "2002", "unstructured": "Liu H, Ye H, Ruskone-Fourmestraux A, et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 2002;122(5):1286\u201394.", "journal-title": "Gastroenterology"}, {"issue": "17", "key": "6_CR000645", "doi-asserted-by": "publisher", "first-page": "3491", "DOI": "10.1200/JCO.2004.10.087", "volume": "22", "author": "SH Kuo", "year": "2004", "unstructured": "Kuo SH, Chen LT, Yeh KH, et al. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas. J Clin Oncol. 2004;22(17):3491\u20137.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "6_CR000646", "doi-asserted-by": "publisher", "first-page": "137", "DOI": "10.1136/gut.2005.081117", "volume": "55", "author": "H Ye", "year": "2006", "unstructured": "Ye H, Gong L, Liu H, et al. Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication. Gut. 2006;55(1):137\u20138.", "journal-title": "Gut"}, {"issue": "6", "key": "6_CR000647", "doi-asserted-by": "publisher", "first-page": "886", "DOI": "10.1136/gut.2004.061663", "volume": "55", "author": "MQ Du", "year": "2006", "unstructured": "Du MQ, Atherton JC. Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management. Gut. 2006;55(6):886\u201393.", "journal-title": "Gut"}, {"issue": "4", "key": "6_CR000648", "doi-asserted-by": "publisher", "first-page": "1147", "DOI": "10.1016/S0002-9440(10)64630-5", "volume": "157", "author": "H Ye", "year": "2000", "unstructured": "Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma. Am J Pathol. 2000;157(4):1147\u201354.", "journal-title": "Am J Pathol"}, {"issue": "4", "key": "6_CR000649", "doi-asserted-by": "publisher", "first-page": "1182", "DOI": "10.1182/blood.V98.4.1182", "volume": "98", "author": "H Liu", "year": "2001", "unstructured": "Liu H, Ye H, Dogan A, et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 2001;98(4):1182\u20137.", "journal-title": "Blood"}, {"issue": "16", "key": "6_CR000650", "doi-asserted-by": "publisher", "first-page": "2490", "DOI": "10.1200/JCO.2006.05.6150", "volume": "24", "author": "X Sagaert", "year": "2006", "unstructured": "Sagaert X, de Paepe P, Libbrecht L, et al. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma. J Clin Oncol. 2006;24(16):2490\u20137.", "journal-title": "J Clin Oncol"}, {"issue": "7", "key": "6_CR000651", "doi-asserted-by": "publisher", "first-page": "1300", "DOI": "10.1038/sj.leu.2404244", "volume": "20", "author": "E Haralambieva", "year": "2006", "unstructured": "Haralambieva E, Adam P, Ventura R, et al. Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia. 2006;20(7):1300\u20133.", "journal-title": "Leukemia"}, {"issue": "6", "key": "6_CR000652", "doi-asserted-by": "publisher", "first-page": "590", "DOI": "10.1016/j.ccr.2010.11.013", "volume": "18", "author": "L Rui", "year": "2010", "unstructured": "Rui L, Emre NC, Kruhlak MJ, et al. Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell. 2010;18(6):590\u2013605.", "journal-title": "Cancer Cell"}, {"issue": "20", "key": "6_CR000653", "doi-asserted-by": "publisher", "first-page": "6426", "DOI": "10.1158/1078-0432.CCR-08-0702", "volume": "14", "author": "U Vinatzer", "year": "2008", "unstructured": "Vinatzer U, Gollinger M, Mullauer L, Raderer M, Chott A, Streubel B. Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3. Clin Cancer Res. 2008;14(20):6426\u201331.", "journal-title": "Clin Cancer Res"}, {"issue": "10", "key": "6_CR000654", "doi-asserted-by": "publisher", "first-page": "1818", "DOI": "10.1038/sj.leu.2403909", "volume": "19", "author": "E Callet-Bauchu", "year": "2005", "unstructured": "Callet-Bauchu E, Baseggio L, Felman P, et al. Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases. Leukemia. 2005;19(10):1818\u201323.", "journal-title": "Leukemia"}, {"issue": "12", "key": "6_CR000655", "doi-asserted-by": "publisher", "first-page": "2467", "DOI": "10.1182/blood-2008-12-194852", "volume": "114", "author": "K Honma", "year": "2009", "unstructured": "Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood. 2009;114(12):2467\u201375.", "journal-title": "Blood"}, {"issue": "20", "key": "6_CR000656", "doi-asserted-by": "publisher", "first-page": "4918", "DOI": "10.1182/blood-2008-08-174110", "volume": "113", "author": "U Novak", "year": "2009", "unstructured": "Novak U, Rinaldi A, Kwee I, et al. The NF-\u039a[KAPPA]B negative regulator TNFAIP3 (A20) is commonly inactivated by somatic mutations and genomic deletions in marginal zone B-cell lymphomas. Blood. 2009;113(20):4918\u201321.", "journal-title": "Blood"}, {"issue": "7247", "key": "6_CR000657", "doi-asserted-by": "publisher", "first-page": "712", "DOI": "10.1038/nature07969", "volume": "459", "author": "M Kato", "year": "2009", "unstructured": "Kato M, Sanada M, Kato I, et al. Frequent inactivation of A20 in B-cell lymphomas. Nature. 2009;459(7247):712\u20136.", "journal-title": "Nature"}, {"issue": "3", "key": "6_CR000658", "doi-asserted-by": "publisher", "first-page": "689", "DOI": "10.1093/annonc/mdq416", "volume": "22", "author": "A Conconi", "year": "2011", "unstructured": "Conconi A, Martinelli G, Lopez-Guillermo A, et al. Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol. 2011;22(3):689\u201395.", "journal-title": "Ann Oncol"}, {"issue": "7", "key": "6_CR000659", "doi-asserted-by": "publisher", "first-page": "2489", "DOI": "10.1182/blood-2002-04-1279", "volume": "101", "author": "E Zucca", "year": "2003", "unstructured": "Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101(7):2489\u201395.", "journal-title": "Blood"}, {"issue": "2", "key": "6_CR000660", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.3324/haematol.11835", "volume": "93", "author": "JP Boer de", "year": "2008", "unstructured": "de Boer JP, Hiddink RF, Raderer M, et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica. 2008;93(2):201\u20136.", "journal-title": "Haematologica"}, {"issue": "3", "key": "6_CR000661", "first-page": "802", "volume": "95", "author": "C Thieblemont", "year": "2000", "unstructured": "Thieblemont C, Berger F, Dumontet C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95(3):802\u20136.", "journal-title": "Blood"}, {"key": "6_CR000662", "doi-asserted-by": "publisher", "first-page": "565", "DOI": "10.1200/JCO.2011.40.6272", "volume": "31", "author": "E Zucca", "year": "2013", "unstructured": "Zucca E, Conconi A, Laszlo D, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol. 2013;31:565\u201372.", "journal-title": "J Clin Oncol."}, {"issue": "5\u20136", "key": "6_CR000663", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.3109/10428199709050889", "volume": "26", "author": "G Pinotti", "year": "1997", "unstructured": "Pinotti G, Zucca E, Roggero E, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 1997;26(5\u20136):527\u201337.", "journal-title": "Leuk Lymphoma"}, {"issue": "18", "key": "6_CR000664", "doi-asserted-by": "publisher", "first-page": "4291", "DOI": "10.1002/cncr.25325", "volume": "116", "author": "A Mazloom", "year": "2010", "unstructured": "Mazloom A, Medeiros LJ, Mclaughlin PW, et al. Marginal zone lymphomas: factors that affect the final outcome. Cancer. 2010;116(18):4291\u20138.", "journal-title": "Cancer"}, {"issue": "1", "key": "6_CR000665", "doi-asserted-by": "publisher", "first-page": "129", "DOI": "10.1093/annonc/mdn563", "volume": "20", "author": "E Boveri", "year": "2009", "unstructured": "Boveri E, Arcaini L, Merli M, et al. Bone marrow histology in marginal zone B-cell lymphomas: correlation with clinical parameters and flow cytometry in 120 patients. Ann Oncol. 2009;20(1):129\u201336.", "journal-title": "Ann Oncol"}, {"issue": "5", "key": "6_CR000666", "doi-asserted-by": "publisher", "first-page": "714", "DOI": "10.1309/HRHQFBFTR8B4LXT4", "volume": "129", "author": "KV Inamdar", "year": "2008", "unstructured": "Inamdar KV, Medeiros LJ, Jorgensen JL, Amin HM, Schlette EJ. Bone marrow involvement by marginal zone B-cell lymphomas of different types. Am J Clin Pathol. 2008;129(5):714\u201322.", "journal-title": "Am J Clin Pathol"}, {"issue": "1", "key": "6_CR000667", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1002/hon.743", "volume": "23", "author": "RW Tsang", "year": "2005", "unstructured": "Tsang RW, Gospodarowicz MK. Radiation therapy for localized low-grade non-Hodgkin\u2019s lymphomas. Hematol Oncol. 2005;23(1):10\u20137.", "journal-title": "Hematol Oncol"}, {"issue": "22", "key": "6_CR000668", "doi-asserted-by": "publisher", "first-page": "4157", "DOI": "10.1200/JCO.2003.06.085", "volume": "21", "author": "RW Tsang", "year": "2003", "unstructured": "Tsang RW, Gospodarowicz MK, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol. 2003;21(22):4157\u201364.", "journal-title": "J Clin Oncol"}, {"key": "6_CR000669", "doi-asserted-by": "publisher", "first-page": "307", "DOI": "10.1182/asheducation-2005.1.307", "volume": "2005", "author": "C Thieblemont", "year": "2005", "unstructured": "Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematol Am Soc Hematol Educ Program. 2005;307\u201313.", "journal-title": "Hematol Am Soc Hematol Educ Program"}, {"issue": "6", "key": "6_CR000670", "doi-asserted-by": "publisher", "first-page": "1086", "DOI": "10.1093/annonc/mdn760", "volume": "20", "author": "A Stathis", "year": "2009", "unstructured": "Stathis A, Chini C, Bertoni F, et al. Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol. 2009;20(6):1086\u201393.", "journal-title": "Ann Oncol"}, {"issue": "Suppl 5", "key": "6_CR000671", "doi-asserted-by": "publisher", "first-page": "v175", "DOI": "10.1093/annonc/mdq182", "volume": "21", "author": "E Zucca", "year": "2010", "unstructured": "Zucca E, Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5Suppl 5:v175\u20136.", "journal-title": "Ann Oncol"}, {"issue": "5", "key": "6_CR000672", "doi-asserted-by": "crossref", "first-page": "397", "DOI": "10.1093/oxfordjournals.annonc.a058869", "volume": "5", "author": "A Rohatiner", "year": "1994", "unstructured": "Rohatiner A, d\u2019Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5(5):397\u2013400.", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "6_CR000673", "doi-asserted-by": "publisher", "first-page": "912", "DOI": "10.1136/gut.52.6.912", "volume": "52", "author": "A Ruskone-Fourmestraux", "year": "2003", "unstructured": "Ruskone-Fourmestraux A, Dragosics B, Morgner A, Wotherspoon A, De Jong D. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003;52(6):912\u20133.", "journal-title": "Gut"}, {"issue": "11", "key": "6_CR000674", "first-page": "1860", "volume": "31", "author": "PP Carbone", "year": "1971", "unstructured": "Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res. 1971;31(11):1860\u20131.", "journal-title": "Cancer Res"}, {"issue": "6", "key": "6_CR000675", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.1136/gut.2010.224949", "volume": "60", "author": "A Ruskone-Fourmestraux", "year": "2011", "unstructured": "Ruskone-Fourmestraux A, Fischbach W, Aleman BM, et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011;60(6):747\u201358.", "journal-title": "Gut"}, {"issue": "8871", "key": "6_CR000676", "doi-asserted-by": "publisher", "first-page": "575", "DOI": "10.1016/0140-6736(93)91409-F", "volume": "342", "author": "AC Wotherspoon", "year": "1993", "unstructured": "Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342(8871):575\u20137.", "journal-title": "Lancet"}, {"issue": "10", "key": "6_CR000677", "doi-asserted-by": "publisher", "first-page": "767", "DOI": "10.7326/0003-4819-122-10-199505150-00006", "volume": "122", "author": "E Roggero", "year": "1995", "unstructured": "Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 1995;122(10):767\u20139.", "journal-title": "Ann Intern Med"}, {"issue": "8965", "key": "6_CR000678", "doi-asserted-by": "publisher", "first-page": "1591", "DOI": "10.1016/S0140-6736(95)90113-2", "volume": "345", "author": "E Bayerdorffer", "year": "1995", "unstructured": "Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995;345(8965):1591\u20134.", "journal-title": "Lancet"}, {"issue": "3", "key": "6_CR000679", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1136/gut.48.3.297", "volume": "48", "author": "A Ruskone-Fourmestraux", "year": "2001", "unstructured": "Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001;48(3):297\u2013303.", "journal-title": "Gut"}, {"issue": "2", "key": "6_CR000680", "doi-asserted-by": "publisher", "first-page": "88", "DOI": "10.7326/0003-4819-131-2-199907200-00003", "volume": "131", "author": "G Steinbach", "year": "1999", "unstructured": "Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131(2):88\u201395.", "journal-title": "Ann Intern Med"}, {"issue": "6", "key": "6_CR000681", "doi-asserted-by": "crossref", "first-page": "1600", "DOI": "10.1200/JCO.2001.19.6.1600", "volume": "19", "author": "C Thiede", "year": "2001", "unstructured": "Thiede C, Wundisch T, Alpen B, et al. Persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa- associated lymphoid tissue B-cell lymphoma. J Clin Oncol. 2001;19(6):1600\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "31", "key": "6_CR000682", "doi-asserted-by": "publisher", "first-page": "8018", "DOI": "10.1200/JCO.2005.02.3903", "volume": "23", "author": "T Wundisch", "year": "2005", "unstructured": "Wundisch T, Thiede C, Morgner A, et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol. 2005;23(31):8018\u201324.", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "6_CR000683", "doi-asserted-by": "publisher", "first-page": "34", "DOI": "10.1136/gut.53.1.34", "volume": "53", "author": "W Fischbach", "year": "2004", "unstructured": "Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut. 2004;53(1):34\u20137.", "journal-title": "Gut"}, {"issue": "9", "key": "6_CR000684", "doi-asserted-by": "publisher", "first-page": "1539", "DOI": "10.1093/annonc/mdi277", "volume": "16", "author": "C Montalban", "year": "2005", "unstructured": "Montalban C, Santon A, Redondo C, et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol. 2005;16(9):1539\u201344.", "journal-title": "Ann Oncol"}, {"issue": "9", "key": "6_CR000685", "doi-asserted-by": "crossref", "first-page": "1324", "DOI": "10.1038/sj.bjc.6603708", "volume": "96", "author": "JS Kim", "year": "2007", "unstructured": "Kim JS, Chung SJ, Choi YS, et al. Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer. 2007;96(9):1324\u20138.", "journal-title": "Br J Cancer"}, {"issue": "3", "key": "6_CR000686", "doi-asserted-by": "publisher", "first-page": "367", "DOI": "10.1111/j.1365-2141.2008.07486.x", "volume": "144", "author": "BW Hancock", "year": "2009", "unstructured": "Hancock BW, Qian W, Linch D, et al. Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. Br J Haematol. 2009;144(3):367\u201375.", "journal-title": "Br J Haematol"}, {"issue": "7", "key": "6_CR000687", "doi-asserted-by": "publisher", "first-page": "2541", "DOI": "10.1182/blood.V99.7.2541", "volume": "99", "author": "F Bertoni", "year": "2002", "unstructured": "Bertoni F, Conconi A, Capella C, et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002;99(7):2541\u20134.", "journal-title": "Blood"}, {"issue": "26", "key": "6_CR000688", "doi-asserted-by": "publisher", "first-page": "6415", "DOI": "10.1200/JCO.2005.05.018", "volume": "23", "author": "F Bertoni", "year": "2005", "unstructured": "Bertoni F, Zucca E. State-of-the-art therapeutics: marginal-zone lymphoma. J Clin Oncol. 2005;23(26):6415\u201320.", "journal-title": "J Clin Oncol"}, {"key": "6_CR000689", "author": "C Copie Bergman", "first-page": "114", "year": "2008", "unstructured": "Copie Bergman C, Wotherspoon A. MALT lymphoma pathology, initial diagnosis and post-treatment evaluation. In: Cavalli F, Stein H, Zucca E, editors. Extranodal lymphomas: pathology and management. London: Informa; 2008. p. 114\u201323.", "volume-title": "Extranodal lymphomas: pathology and management", "DOI": "10.3109/9780203091753-13", "doi-asserted-by": "publisher"}, {"issue": "11", "key": "6_CR000690", "doi-asserted-by": "publisher", "first-page": "1656", "DOI": "10.1136/gut.52.11.1656", "volume": "52", "author": "C Copie-Bergman", "year": "2003", "unstructured": "Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut. 2003;52(11):1656.", "journal-title": "Gut"}, {"key": "6_CR000900", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1111/bjh.12078", "volume": "160", "author": "C Copie-Bergman", "year": "2013", "unstructured": "Copie-Bergman C, Wotherspoon AC, Capella C, et al. Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol. 2013;160:47\u201352.", "journal-title": "Br J Haematol."}, {"issue": "12", "key": "6_CR000691", "first-page": "1147", "volume": "25", "author": "J Yahalom", "year": "2011", "unstructured": "Yahalom J. Patients with H pylori-independent MALT lymphoma are curable with radiotherapy. Oncology (Williston Park). 2011;25(12):1147\u20139.", "journal-title": "Oncology (Williston Park)"}, {"key": "6_CR000692", "doi-asserted-by": "publisher", "first-page": "a1454", "DOI": "10.1136/bmj.a1454", "volume": "337", "author": "L Fuccio", "year": "2008", "unstructured": "Fuccio L, Laterza L, Zagari RM, Cennamo V, Grilli D, Bazzoli F. Treatment of Helicobacter pylori infection. BMJ. 2008;337:a1454.", "journal-title": "BMJ"}, {"issue": "6", "key": "6_CR000693", "doi-asserted-by": "publisher", "first-page": "772", "DOI": "10.1136/gut.2006.101634", "volume": "56", "author": "P Malfertheiner", "year": "2007", "unstructured": "Malfertheiner P, Megraud F, O\u2019Morain C, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56(6):772\u201381.", "journal-title": "Gut"}, {"issue": "8", "key": "6_CR000694", "doi-asserted-by": "publisher", "first-page": "1808", "DOI": "10.1111/j.1572-0241.2007.01393.x", "volume": "102", "author": "WD Chey", "year": "2007", "unstructured": "Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol. 2007;102(8):1808\u201325.", "journal-title": "Am J Gastroenterol"}, {"issue": "19", "key": "6_CR000695", "doi-asserted-by": "publisher", "first-page": "3136", "DOI": "10.1200/JCO.2006.06.0723", "volume": "24", "author": "M Raderer", "year": "2006", "unstructured": "Raderer M, Wohrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol. 2006;24(19):3136\u201341.", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "6_CR000696", "doi-asserted-by": "publisher", "first-page": "398", "DOI": "10.1111/j.1523-5378.2005.00347.x", "volume": "10", "author": "D Groote De", "year": "2005", "unstructured": "De Groote D, Van Doorn LJ, Van den Bulck K, et al. Detection of non-pylori Helicobacter species in \u201cHelicobacter heilmannii\u201d-infected humans. Helicobacter. 2005;10(5):398\u2013406.", "journal-title": "Helicobacter"}, {"issue": "5", "key": "6_CR000697", "doi-asserted-by": "publisher", "first-page": "821", "DOI": "10.1016/S0016-5085(00)70167-3", "volume": "118", "author": "A Morgner", "year": "2000", "unstructured": "Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology. 2000;118(5):821\u20138.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "6_CR000698", "doi-asserted-by": "publisher", "first-page": "1087", "DOI": "10.1053/gast.1997.v113.pm9322502", "volume": "113", "author": "M Sackmann", "year": "1997", "unstructured": "Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after \u00aderadication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology. 1997;113(4):1087\u201390.", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "6_CR000699", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1136/gut.48.4.454", "volume": "48", "author": "S Nakamura", "year": "2001", "unstructured": "Nakamura S, Matsumoto T, Suekane H, et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut. 2001;48(4):454\u201360.", "journal-title": "Gut"}, {"issue": "10", "key": "6_CR0006100", "doi-asserted-by": "publisher", "first-page": "1715", "DOI": "10.1046/j.1365-2036.2002.01334.x", "volume": "16", "author": "G Caletti", "year": "2002", "unstructured": "Caletti G, Zinzani PL, Fusaroli P, et al. The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Aliment Pharmacol Ther. 2002;16(10):1715\u201322.", "journal-title": "Aliment Pharmacol Ther"}, {"issue": "18", "key": "6_CR0006101", "doi-asserted-by": "publisher", "first-page": "1350", "DOI": "10.1093/jnci/89.18.1350", "volume": "89", "author": "A Neubauer", "year": "1997", "unstructured": "Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 1997;89(18):1350\u20135.", "journal-title": "J Natl Cancer Inst"}, {"issue": "7", "key": "6_CR0006102", "doi-asserted-by": "publisher", "first-page": "937", "DOI": "10.1023/A:1011122904602", "volume": "12", "author": "M Raderer", "year": "2001", "unstructured": "Raderer M, Osterreicher C, Machold K, et al. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol. 2001;12(7):937\u20139.", "journal-title": "Ann Oncol"}, {"issue": "12", "key": "6_CR0006103", "first-page": "4014", "volume": "95", "author": "B Alpen", "year": "2000", "unstructured": "Alpen B, Neubauer A, Dierlamm J, et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood. 2000;95(12):4014\u20135.", "journal-title": "Blood"}, {"issue": "22", "key": "6_CR0006104", "doi-asserted-by": "publisher", "first-page": "5061", "DOI": "10.1200/JCO.2005.05.660", "volume": "23", "author": "M Levy", "year": "2005", "unstructured": "Levy M, Copie-Bergman C, Gameiro C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol. 2005;23(22):5061\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "6", "key": "6_CR0006105", "doi-asserted-by": "publisher", "first-page": "1387", "DOI": "10.1007/s00280-011-1631-y", "volume": "68", "author": "SH Kuo", "year": "2011", "unstructured": "Kuo SH, Cheng AL, Lin CW, et al. t(11;18)(q21;q21) translocation as predictive marker for non-\u00adresponsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. Cancer Chemother Pharmacol. 2011;68(6):1387\u201395.", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "9", "key": "6_CR0006106", "doi-asserted-by": "publisher", "first-page": "1979", "DOI": "10.1200/JCO.2005.08.128", "volume": "23", "author": "G Martinelli", "year": "2005", "unstructured": "Martinelli G, Laszlo D, Ferreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23(9):1979\u201383.", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "6_CR0006107", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.3109/10428190903431820", "volume": "51", "author": "M Levy", "year": "2010", "unstructured": "Levy M, Copie-Bergman C, Molinier-Frenkel V, et al. Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma. 2010;51(2):284\u201390.", "journal-title": "Leuk Lymphoma"}, {"issue": "6", "key": "6_CR0006108", "doi-asserted-by": "publisher", "first-page": "476", "DOI": "10.1159/000079502", "volume": "66", "author": "B Streubel", "year": "2004", "unstructured": "Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Oncology. 2004;66(6):476\u201380.", "journal-title": "Oncology"}, {"issue": "33", "key": "6_CR0006109", "doi-asserted-by": "publisher", "first-page": "8442", "DOI": "10.1200/JCO.2004.00.8532", "volume": "23", "author": "M Raderer", "year": "2005", "unstructured": "Raderer M, W\u00f6hrer S, Bartsch R, et al. Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma. J Clin Oncol. 2005;23(33):8442\u20136.", "journal-title": "J Clin Oncol"}, {"issue": "12", "key": "6_CR0006110", "first-page": "3885", "volume": "95", "author": "MQ Du", "year": "2000", "unstructured": "Du MQ, Peng H, Liu H, et al. BCL10 gene mutation in lymphoma. Blood. 2000;95(12):3885\u201390.", "journal-title": "Blood"}, {"issue": "12", "key": "6_CR0006111", "doi-asserted-by": "publisher", "first-page": "1685", "DOI": "10.1136/gut.2006.096420", "volume": "56", "author": "W Fischbach", "year": "2007", "unstructured": "Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, et al. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut. 2007;56(12):1685\u20137.", "journal-title": "Gut"}, {"key": "6_CR0006901", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1136/gutjnl-2011-300495", "volume": "61", "author": "S Nakamura", "year": "2012", "unstructured": "Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61:507\u201313.", "journal-title": "Gut."}, {"issue": "16", "key": "6_CR0006112", "doi-asserted-by": "publisher", "first-page": "2470", "DOI": "10.1016/j.ejca.2008.07.005", "volume": "44", "author": "LG Capelle", "year": "2008", "unstructured": "Capelle LG, de Vries AC, Looman CW, et al. Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer. 2008;44(16):2470\u20136.", "journal-title": "Eur J Cancer"}, {"issue": "6", "key": "6_CR0006113", "doi-asserted-by": "publisher", "first-page": "411", "DOI": "10.1159/000098555", "volume": "70", "author": "M Raderer", "year": "2006", "unstructured": "Raderer M, Wohrer S, Streubel B, et al. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma. Oncology. 2006;70(6):411\u20137.", "journal-title": "Oncology"}, {"issue": "16", "key": "6_CR0006114", "doi-asserted-by": "publisher", "first-page": "3815", "DOI": "10.1002/cncr.25226", "volume": "116", "author": "JS Goda", "year": "2010", "unstructured": "Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-\u00adassociated lymphoid tissue lymphomas treated with radiotherapy. Cancer. 2010;116(16):3815\u201324.", "journal-title": "Cancer"}, {"issue": "Suppl 3", "key": "6_CR0006115", "first-page": "B100", "volume": "80", "author": "J Yahalom", "year": "2001", "unstructured": "Yahalom J. MALT lymphomas: a radiation oncology viewpoint. Ann Hematol. 2001;80 Suppl 3Suppl 3:B100\u20135.", "journal-title": "Ann Hematol"}, {"issue": "28", "key": "6_CR0006116", "doi-asserted-by": "publisher", "first-page": "7050", "DOI": "10.1200/JCO.2005.04.031", "volume": "23", "author": "P Koch", "year": "2005", "unstructured": "Koch P, Probst A, Berdel WE, et al. Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol. 2005;23(28):7050\u20139.", "journal-title": "J Clin Oncol"}, {"issue": "10", "key": "6_CR0006117", "doi-asserted-by": "publisher", "first-page": "2190", "DOI": "10.1002/cncr.20237", "volume": "100", "author": "PL Zinzani", "year": "2004", "unstructured": "Zinzani PL, Stefoni V, Musuraca G, et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer. 2004;100(10):2190\u20134.", "journal-title": "Cancer"}, {"issue": "4", "key": "6_CR0006118", "first-page": "ECR01", "volume": "89", "author": "G Jager", "year": "2004", "unstructured": "Jager G, Hofler G, Linkesch W, Neumeister P. Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica. 2004;89(4):ECR01.", "journal-title": "Haematologica"}, {"issue": "12", "key": "6_CR0006119", "doi-asserted-by": "publisher", "first-page": "1758", "DOI": "10.1093/annonc/mdg492", "volume": "14", "author": "S Wohrer", "year": "2003", "unstructured": "Wohrer S, Drach J, Hejna M, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol. 2003;14(12):1758\u201361.", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "6_CR0006120", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1111/j.1365-2141.2009.07677.x", "volume": "145", "author": "JR Brown", "year": "2009", "unstructured": "Brown JR, Friedberg JW, Feng Y, et al. A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol. 2009;145(6):741\u20138.", "journal-title": "Br J Haematol"}, {"issue": "19", "key": "6_CR0006121", "doi-asserted-by": "publisher", "first-page": "1348", "DOI": "10.1093/jnci/djj406", "volume": "98", "author": "E Zucca", "year": "2006", "unstructured": "Zucca E, Bertoni F. Chlamydia or not Chlamydia, that is the question: which is the microorganism associated with MALT lymphomas of the ocular adnexa? J Natl Cancer Inst. 2006;98(19):1348\u20139.", "journal-title": "J Natl Cancer Inst"}, {"issue": "5", "key": "6_CR0006122", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1093/annonc/mdm513", "volume": "19", "author": "AJ Ferreri", "year": "2008", "unstructured": "Ferreri AJ, Dolcetti R, Du MQ, et al. Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol. 2008;19(5):835\u201346.", "journal-title": "Ann Oncol"}, {"key": "6_CR0006123", "first-page": "267", "volume": "118", "author": "S Govi", "year": "2011", "unstructured": "Ferreri AJ, Govi S, Pasini E, et al. Chlamydophila psittaci eradication with doxycycline as first-line \u00adtargeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012;30:2988\u201394.", "journal-title": "Blood (ASH Annu Meeting Abstr)"}, {"issue": "18", "key": "6_CR0006124", "doi-asserted-by": "publisher", "first-page": "1345", "DOI": "10.1093/jnci/dji277", "volume": "97", "author": "LT Chen", "year": "2005", "unstructured": "Chen LT, Lin JT, Tai JJ, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97(18):1345\u201353.", "journal-title": "J Natl Cancer Inst"}, {"issue": "21", "key": "6_CR0006902", "doi-asserted-by": "crossref", "first-page": "4838", "DOI": "10.1182/blood-2012-01-404194", "volume": "119", "author": "SH Kuo", "year": "2012", "unstructured": "Kuo SH, Yeh KH, Wu MS, et al. Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomas. Blood. 2012;119(21):4838\u201344; quiz 5057.", "journal-title": "Blood"}, {"issue": "18", "key": "6_CR0006903", "doi-asserted-by": "publisher", "first-page": "1345", "DOI": "10.1093/jnci/dji277", "volume": "97", "author": "LT Chen", "year": "2005", "unstructured": "M\u00f6ller P, Viardot A. Antibiotics as first-line therapy for Hp-associated gastric large B-cell lymphoma? Probably yes. Blood. 2012;119:4818\u20139; doi:\n                  10.1182/blood-2012-03-417345\n                  \n                .", "journal-title": "J Natl Cancer Inst"}], "container-title": ["Lymphoma"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-1-62703-408-1_6", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T23:39:58Z", "timestamp": 1558222798000}, "score": 57.669083, "issued": {"date-parts": [[2013]]}, "ISBN": ["9781627034074", "9781627034081"], "references-count": 128, "URL": "http://dx.doi.org/10.1007/978-1-62703-408-1_6", "relation": {"cites": []}, "assertion": [{"value": "15 April 2013", "order": 1, "name": "first_online", "label": "First Online", "group": {"name": "ChapterHistory", "label": "Chapter History"}}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:14:06Z", "timestamp": 1575530046678}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "21", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 11, 19]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Abstract 432</jats:p>\n               <jats:p>The IELSG-19 study was launched in 2003 by the International Extranodal Lymphoma Study Group to compare Chlorambucil alone versus the combination of Chlorambucil and Rituximab in the treatment of MALT lymphomas. Main contributors were the Italian Lymphoma Intergroup, the French GELA Group, the UK NCRI Group, the Catalan Hematology Group and the Oncology Institute of Southern Switzerland. MALT lymphoma pts with localized disease at any extranodal site who did not respond or were not suitable for local therapy (including H.pylori-negative gastric lymphomas or those who failed antibiotic therapy) were eligible, as well as those with disseminated or multifocal MALT lymphoma. Central histology review was performed. In arm A, Chlorambucil was given 6 mg/m2 daily p.o for 42 consecutive days (d 1\u201342). After restaging, responding patients and those with stable disease were kept on Chlorambucil 6 mg/m2 daily p.o for 14 consecutive days every 28 days for 4 cycles (d 56\u201370, 84\u201398, 112\u2013126, 140\u2013154). In arm B, Chlorambucil was given as in arm A, together with Rituximab, 375 mg/m2 iv on day 1, 8, 15, 22, 56, 84, 112 and 140. Because of the excellent initial recruitment a third arm with Rituximab alone (with a randomisation rate of 1:1:6) was introduced in 2006. The study planned accrual of 450 patients was reached in June 2010. A planned final analysis was performed according to protocol on the 227 pts enrolled in the first two arms before introduction of the third treatment arm: 119 men (52%) and 108 women (48%); 204 (90%) with no previous treatment. The sample size allowed the detection of a 20% improvement in event-free survival (EFS, main endpoint) with 5% significance and 80% power. The treatment was completed as per protocol in 86% of the 227 pts analysed (89% in Arm A and 80% in arm B, respectively), in 60% without any dose adjustment or delay. The primary MALT lymphoma site was the stomach in 94 pts (41%);133 pts (59%) had a non-gastric presentation. In 79 pts (35%) the lymphoma involved more than 1 extranodal site. Lymph node involvement was present in 85 pts (37%); 133 pts (59%) had localized disease (Ann Arbor stage I-II). The ECOG performance status was 0 in 168 pts (74%). According to the international prognostic index (IPI) 133 pts (59%) had a low risk, 48 (21%) a low-intermediate risk, 39 (17%) an intermediate-high risk, and only 7 (3%) a high risk score. B-symptoms were present in 21 pts (9%) and LDH levels were higher than normal in 17 (7%). The main risk factors were equally distributed between the two arms. Outcome analysis was performed on all randomised patients on an intent-to-treat basis, median follow-up time is 60 months. The 5-year EFS was significantly better for the patients treated with Chlorambucil plus Rituximab (68%; 95% CI, 58%-76%) in comparison with those receiving Chlorambucil alone (50%; 95% CI, 40%-59%). Overall survival (OS) at 5 years was identical in the two arms (88%). There was no outcome difference between pts with gastric and non-gastric localization (note that H. pylori-positive gastric MALT lymphoma pts still responding to antibiotics were not eligible). Among the main clinical characteristics, more than one extranodal site, advanced stage, the presence of lymph nodal involvement and an unfavourable IPI were significantly associated with shorter EFS and OS. With respect to toxicity, both treatments were well tolerated and no unexpected side effects were recorded. Severe hematologic toxicity was uncommon in both arms but grade 3\u20134 neutropenia was significantly more frequent in the Chlorambucil plus Rituximab arm (19 vs. 2 episodes, p&lt;0.001). In conclusion, this is the largest randomised trial ever conducted in MALT lymphoma. While awaiting the analysis of the whole study (to include the third arm with Rituximab alone, added later on), the current results confirm the activity of Rituximab in combination with chemotherapy but also indicate that differences in EFS and response rate may not automatically translate into improved survival overall.</jats:p>\n               <jats:p>Table 1. All Arm A Chlorambucil Arm B R-Chlorambucil p-value n 227 113 114 sex (M/F) 119/108 63/50 56/58 n.s. median age (years) 60 60 59 n.s. previously untreated 204 100 104 n.s. primary gastric site 94 48 46 n.s. primary non-gastric site 133 65 68 n.s. lymph node involvement 85 42 43 n.s. low to low-intermediate IPI 181 90 91 n.s. median follow up (months) 60 60 62 n.s. 5-year EFS 59% 50% 68% 0.0024 best response -CR 71% 65% 78% 0.017 -PR 19% 22% 16% 5-yr OS 88% 88% 88% n.s.</jats:p>\n               <jats:p>Figure 1. Figure 1.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosure:</jats:title>\n                  <jats:p>Zucca: Roche: Research Funding; Mundipharma: Honoraria, Research Funding; Celgene: Membership on an entity's Board of Directors or advisory committees. Off Label Use: Among indolent lymphomas, Rituximab is not specifically approved for MALT lymphoma but only for follicular lymphoma. Johnson:Roche: Membership on an entity's Board of Directors or advisory committees. Vitolo:Roche: Membership on an entity's Board of Directors or advisory committees. Coiffier:Roche: Research Funding. Morschhauser:Roche: Honoraria. Pettengell:Roche: Honoraria.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v116.21.432.432", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T19:53:18Z", "timestamp": 1570909998000}, "page": "432-432", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study"], "prefix": "10.1182", "volume": "116", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": [{"name": "Oncology Institute of Southern Switzerland, Bellinzona, Switzerland,"}]}, {"given": "Annarita", "family": "Conconi", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy,"}]}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, European Institute of Oncology, Milan, Italy,"}]}, {"given": "Maurizio", "family": "Martelli", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, \u201cSapienza\u201d University, Rome, Italy,"}]}, {"given": "Catherine", "family": "Thieblemont", "sequence": "additional", "affiliation": [{"name": "Hematology - INSERM U728- IUH-, Hopital Saint Louis, Paris, France,"}]}, {"given": "Peter W", "family": "Johnson", "sequence": "additional", "affiliation": [{"name": "School of Medicine CR UK Centre, Southampton General Hospital, Southampton, United Kingdom,"}]}, {"given": "Armando", "family": "Lopez-Guillermo", "sequence": "additional", "affiliation": [{"name": "Department of Hematology, Hospital Clinic, Barcelona, Spain,"}]}, {"given": "Reda", "family": "Bouabdallah", "sequence": "additional", "affiliation": [{"name": "Institut Paoli-Calmettes, Marseille, France,"}]}, {"given": "Alessandra", "family": "Tucci", "sequence": "additional", "affiliation": [{"name": "Ematologia, Spedali Civili, Brescia, Italy,"}]}, {"given": "Umberto", "family": "Vitolo", "sequence": "additional", "affiliation": [{"name": "Chair of Haematology, University of Torino, Torino, Italy,"}]}, {"given": "Bertrand", "family": "Coiffier", "sequence": "additional", "affiliation": [{"name": "Centre Hospitalier Lyon-Sud, Pierre-Benite, France,"}]}, {"given": "Liliana", "family": "Devizzi", "sequence": "additional", "affiliation": [{"name": "Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy,"}]}, {"given": "Fabrice", "family": "Jardin", "sequence": "additional", "affiliation": [{"name": "Hematology, Centre Henri Becquerel, Rouen, France,"}]}, {"given": "Catherine", "family": "Sebban", "sequence": "additional", "affiliation": [{"name": "Centre Le\u0301on Be\u0301rard, Lyon, France,"}]}, {"given": "Graziella", "family": "Pinotti", "sequence": "additional", "affiliation": [{"name": "UO Oncologia Medica, Ospedale di Circolo Fondazione Macchi, Varese, Italy,"}]}, {"given": "Franck", "family": "Morschhauser", "sequence": "additional", "affiliation": [{"name": "Hematology Department, Ho\u0302pital Claude Huriez, Lille, France,"}]}, {"given": "Ruth", "family": "Pettengell", "sequence": "additional", "affiliation": [{"name": "Haematology, St George's University of London, London, United Kingdom,"}]}, {"given": "Andre", "family": "Bosly", "sequence": "additional", "affiliation": [{"name": "Hematology, UCL Mont Godinne, Yvoir, Belgium,"}]}, {"given": "Emili", "family": "Montserrat", "sequence": "additional", "affiliation": [{"name": "Department of Hematology, Hospital Clinic, Barcelona, Spain,"}]}, {"given": "Monica", "family": "Bellei", "sequence": "additional", "affiliation": [{"name": "Dipartimento di Oncologia ed Ematologia, Universita' di Modena e Reggio Emilia, Modena, Italy,"}]}, {"given": "Stefano A.", "family": "Pileri", "sequence": "additional", "affiliation": [{"name": "Dept. of Hematology/Oncology, University of Bologna, Bologna, Italy,"}]}, {"given": "Christiane", "family": "Copie-Bergman", "sequence": "additional", "affiliation": [{"name": "Pathology Department, Hopital Henri Mondor, Paris Cre\u0301teil Cedex, France,"}]}, {"given": "Elias", "family": "Campo", "sequence": "additional", "affiliation": [{"name": "Pathology, Hospital Clinic, Barcelona, Spain,"}]}, {"given": "Andrew", "family": "Jack", "sequence": "additional", "affiliation": [{"name": "Hem. Malignancy Diagnostic Serv., St James's University Hospital, Leeds, United Kingdom,"}]}, {"given": "Luca", "family": "Mazzucchelli", "sequence": "additional", "affiliation": [{"name": "Istituto Cantonale di Patologia, Locarno, Switzerland"}]}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": [{"name": "Oncology Institute of Southern Switzerland, Bellinzona, Switzerland,"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/116/21/432/68012/Chlorambucil-Plus-Rituximab-Produces-Better", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/116/21/432/68012/Chlorambucil-Plus-Rituximab-Produces-Better", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 16]], "date-time": "2019-11-16T14:31:31Z", "timestamp": 1573914691000}, "score": 53.492496, "issued": {"date-parts": [[2010, 11, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 11, 19]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1182/blood.v116.21.432.432", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T19:49:27Z", "timestamp": 1574365767555}, "reference-count": 104, "publisher": "Informa UK Limited", "issue": "1-2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[1999, 1]]}, "DOI": "10.3109/10428199909145705", "type": "journal-article", "created": {"date-parts": [[2008, 4, 24]], "date-time": "2008-04-24T04:13:08Z", "timestamp": 1209010388000}, "page": "57-68", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Molecular Genetics of Extranodal Marginal Zone (MALT-Type) B-Cell Lymphoma"], "prefix": "10.1080", "volume": "35", "author": [{"given": "Francesco", "family": "Bertoni", "sequence": "first", "affiliation": [{"name": "Servizio Oncologico Canionale, Ospedale San Giovanni, Bellinzona, Swiizerland"}, {"name": "Molecular Pharmacology Unit, Department of Oncology, Istituto di Ricerche Farmacologiche \u201cMario Negri\u201d, Milan, Italy"}]}, {"given": "Finbarr E.", "family": "Cotter", "sequence": "additional", "affiliation": [{"name": "LRF Department of Haematology and Oncology, Insitute of Child Health, University College London, Uniied Kingdom"}]}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": [{"name": "Servizio Oncologico Canionale, Ospedale San Giovanni, Bellinzona, Swiizerland"}]}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "CIT0001", "author": "Isaacson P. G", "volume": "6", "first-page": "319", "year": "1995", "journal-title": "Annals of Oncology", "DOI": "10.1093/oxfordjournals.annonc.a059177", "doi-asserted-by": "crossref"}, {"key": "CIT0002", "DOI": "10.1093/oxfordjournals.annonc.a010756", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "author": "Spencer J.", "volume": "30", "first-page": "213", "year": "1997", "journal-title": "Helicobacrer pylori. Cancer Surveys"}, {"key": "CIT0004", "DOI": "10.1146/annurev.med.49.1.289", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1046/j.1365-2141.1998.00513.x", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "author": "Harris N. I.", "volume": "84", "first-page": "1361", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0007", "DOI": "10.1023/A:1008278706002", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1056/NEJM199803193381205", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "author": "Ott G.", "volume": "57", "first-page": "3944", "year": "1997", "journal-title": "Cancer Research"}, {"key": "CIT0010", "DOI": "10.1023/A:1008202303666", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "author": "Wotherspoon A. C.", "volume": "85", "first-page": "2000", "year": "1995", "journal-title": "Blood"}, {"key": "CIT0012", "author": "Dierlamm J.", "volume": "87", "first-page": "299", "year": "1996", "journal-title": "Blood"}, {"key": "CIT0013", "author": "Brynes R. K.", "volume": "9", "first-page": "995", "year": "1996", "journal-title": "Modern Pathology"}, {"key": "CIT0014", "author": "Whang-Peng J.", "first-page": "277", "year": "1997", "volume-title": "The non-Hodgkin's lymphomas, 2nd edn"}, {"issue": "1", "key": "CIT0015", "first-page": "240a", "volume": "92", "author": "Hoeve M. A.", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0016", "DOI": "10.1016/S0002-9440(10)65611-8", "doi-asserted-by": "publisher"}, {"key": "CIT0017", "author": "Rosenwald A.", "volume": "92", "issue": "1", "first-page": "184b", "journal-title": "Blood"}, {"issue": "1", "key": "CIT0018", "first-page": "240a", "volume": "92", "author": "Dierlamm J.", "year": "1998", "journal-title": "Blood"}, {"issue": "1", "key": "CIT0019", "first-page": "70a", "volume": "92", "author": "Stilgenbauer S.", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0020", "DOI": "10.1016/0165-4608(92)90130-Z", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0021", "first-page": "508a", "volume": "92", "author": "Zhang Q.", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0022", "DOI": "10.1038/sj.leu.2400635", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1002/path.1711620206", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1002/path.1711660208", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "author": "Royer B.", "volume": "90", "first-page": "766", "year": "1997", "journal-title": "Blood"}, {"key": "CIT0026", "DOI": "10.1023/A:1008327301372", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "DOI": "10.1056/NEJM199407143310202", "doi-asserted-by": "publisher"}, {"key": "CIT0028", "DOI": "10.1046/j.1365-2141.1997.2703087.x", "doi-asserted-by": "publisher"}, {"key": "CIT0029", "DOI": "10.1046/j.1365-2141.1997.4443254.x", "doi-asserted-by": "publisher"}, {"key": "CIT0030", "author": "Houldsworth J.", "volume": "87", "first-page": "25", "year": "1996", "journal-title": "Blood"}, {"key": "CIT0031", "author": "Barth T. F.", "volume": "91", "first-page": "4321", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0032", "author": "Joos S.", "volume": "87", "first-page": "1571", "year": "1996", "journal-title": "Blood"}, {"key": "CIT0033", "author": "Raghoebier S.", "volume": "78", "first-page": "2680", "year": "1991", "journal-title": "Blood"}, {"key": "CIT0034", "DOI": "10.1093/annonc/2.suppl_2.93", "doi-asserted-by": "publisher"}, {"key": "CIT0035", "DOI": "10.1002/(SICI)1096-9896(199704)181:4<381::AID-PATH787>3.0.CO;2-I", "doi-asserted-by": "publisher"}, {"key": "CIT0036", "DOI": "10.1046/j.1365-2141.1997.2403057.x", "doi-asserted-by": "publisher"}, {"key": "CIT0037", "author": "Du M.", "volume": "86", "first-page": "4587", "year": "1995", "journal-title": "Blood"}, {"key": "CIT0038", "author": "Levy V.", "volume": "9", "first-page": "245", "year": "1996", "journal-title": "Modern Pathology"}, {"key": "CIT0039", "DOI": "10.1002/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO;2-Y", "doi-asserted-by": "publisher"}, {"key": "CIT0040", "DOI": "10.1053/gast.1997.v112.pm9178679", "doi-asserted-by": "publisher"}, {"key": "CIT0041", "DOI": "10.1038/sj.leu.2400579", "doi-asserted-by": "publisher"}, {"key": "CIT0042", "DOI": "10.3109/10428199609051724", "doi-asserted-by": "publisher"}, {"key": "CIT0043", "author": "Ruas M.", "volume": "1378", "first-page": "F115", "year": "1998", "journal-title": "Biochimica et Biophysica Acta"}, {"key": "CIT0044", "DOI": "10.1038/sj.leu.2401009", "doi-asserted-by": "publisher"}, {"key": "CIT0045", "DOI": "10.1126/science.281.5381.1305", "doi-asserted-by": "publisher"}, {"key": "CIT0046", "author": "Gronbaek K.", "volume": "92", "first-page": "3018", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0047", "author": "Loeb L. A", "volume": "54", "first-page": "5059", "year": "1994", "journal-title": "Cancer Res."}, {"key": "CIT0048", "author": "Gamberi B.", "volume": "89", "first-page": "975", "year": "1997", "journal-title": "Blood"}, {"key": "CIT0049", "author": "Peng H.", "volume": "148", "first-page": "643", "year": "1996", "journal-title": "American Journal of Pathology"}, {"key": "CIT0050", "DOI": "10.1002/(SICI)1097-0215(19980529)76:5<635::AID-IJC4>3.0.CO;2-R", "doi-asserted-by": "publisher"}, {"key": "CIT0051", "author": "Zucca E.", "volume": "6", "first-page": "726", "year": "1995", "journal-title": "Annals of Oncology", "DOI": "10.1093/oxfordjournals.annonc.a059292", "doi-asserted-by": "crossref"}, {"key": "CIT0052", "DOI": "10.1046/j.1365-2141.1996.d01-1791.x", "doi-asserted-by": "publisher"}, {"key": "CIT0053", "author": "Du M. Q.", "volume": "8", "first-page": "162", "year": "1998", "journal-title": "Trends in Experimental and Clinical Medicine"}, {"key": "CIT0054", "unstructured": "Male D., Cooke A., Owen M., Trowsdale J., Champion B. Advanced immunology, 3rd edn. Mosby, London 1996; 3\u20133, pp. 1.11, 9. 19. 16."}, {"key": "CIT0055", "author": "Stewart A. K.", "volume": "83", "first-page": "1717", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0056", "author": "Raffeld M", "first-page": "277", "year": "1997", "volume-title": "The non-Hodgkin's lymphomas, 2nd edn."}, {"key": "CIT0057", "DOI": "10.1385/0-89603-341-4:3", "doi-asserted-by": "publisher"}, {"key": "CIT0058", "DOI": "10.1002/path.1711690303", "doi-asserted-by": "publisher"}, {"key": "CIT0059", "DOI": "10.1111/j.1365-2559.1994.tb00532.x", "doi-asserted-by": "publisher"}, {"key": "CIT0060", "DOI": "10.1002/(SICI)1096-9896(199609)180:1<26::AID-PATH681>3.0.CO;2-X", "doi-asserted-by": "publisher"}, {"key": "CIT0061", "author": "Chan J. K. C", "volume": "13", "first-page": "260", "year": "1996", "journal-title": "Seminars in Diagnostic Pathology"}, {"key": "CIT0062", "author": "Van Krieken J. H. J. M.", "first-page": "157", "year": "1997", "volume-title": "Gastric MALT-Lymphoma. Studies on diagnosis, pathogenesis and treatment"}, {"key": "CIT0063", "DOI": "10.1016/S0046-8177(97)90101-5", "doi-asserted-by": "publisher"}, {"key": "CIT0064", "author": "Diss T. C.", "volume": "181", "first-page": "9A", "year": "1997", "journal-title": "Journal of Pathology"}, {"key": "CIT0065", "DOI": "10.1023/A:1008257512411", "doi-asserted-by": "publisher"}, {"key": "CIT0066", "DOI": "10.1093/jnci/89.18.1350", "doi-asserted-by": "publisher"}, {"key": "CIT0067", "DOI": "10.1016/S1079-2104(05)80307-5", "doi-asserted-by": "publisher"}, {"key": "CIT0068", "author": "Hsi E. D.", "volume": "106", "first-page": "498", "year": "1996", "journal-title": "American Journal of Clinical Pathology", "DOI": "10.1093/ajcp/106.4.498", "doi-asserted-by": "crossref"}, {"key": "CIT0069", "DOI": "10.1016/S0046-8177(97)90161-1", "doi-asserted-by": "publisher"}, {"key": "CIT0070", "author": "Bahler D. W.", "volume": "89", "first-page": "3335", "year": "1997", "journal-title": "Blood"}, {"key": "CIT0071", "author": "Bahler D. W.", "volume": "91", "first-page": "1864", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0072", "DOI": "10.1111/j.1365-2249.1990.tb05174.x", "doi-asserted-by": "publisher"}, {"key": "CIT0073", "author": "Hsi E. D.", "volume": "27", "first-page": "290", "year": "1996", "journal-title": "Helicobacter pylon. Human Pathology"}, {"key": "CIT0074", "author": "Hsi E. D.", "volume": "110", "first-page": "327", "year": "1998", "journal-title": "American Journal of Clinical Pathology", "DOI": "10.1093/ajcp/110.3.327", "doi-asserted-by": "crossref"}, {"key": "CIT0075", "DOI": "10.1016/S0046-8177(98)90446-4", "doi-asserted-by": "publisher"}, {"key": "CIT0076", "DOI": "10.1016/0140-6736(93)91409-F", "doi-asserted-by": "publisher"}, {"key": "CIT0077", "author": "Rudolph B.", "volume": "15", "first-page": "1104", "year": "1997", "journal-title": "Journal of Clinical Oncology", "DOI": "10.1200/JCO.1997.15.3.1104", "doi-asserted-by": "crossref"}, {"key": "CIT0078", "author": "Savio A.", "volume": "87", "first-page": "1255", "year": "1996", "journal-title": "Blood"}, {"key": "CIT0079", "DOI": "10.1038/381751a0", "doi-asserted-by": "publisher"}, {"key": "CIT0080", "author": "Qin Y.", "volume": "86", "first-page": "3528", "year": "1995", "journal-title": "Blood"}, {"key": "CIT0081", "author": "Du M.", "volume": "10", "first-page": "1190", "year": "1996", "journal-title": "Leukemia"}, {"key": "CIT0082", "DOI": "10.1136/mp.49.1.M29", "doi-asserted-by": "publisher"}, {"key": "CIT0083", "author": "Du M.", "volume": "88", "first-page": "4445", "year": "1996", "journal-title": "Blood"}, {"key": "CIT0084", "author": "Aarts W. M.", "volume": "92", "first-page": "3857", "year": "1998", "journal-title": "Blood"}, {"key": "CIT0085", "DOI": "10.1046/j.1365-2141.1997.1392954.x", "doi-asserted-by": "publisher"}, {"key": "CIT0086", "DOI": "10.1084/jem.170.1.39", "doi-asserted-by": "publisher"}, {"key": "CIT0087", "author": "Sanz I.", "volume": "152", "first-page": "3958", "year": "1994", "journal-title": "Journal of Immunology"}, {"key": "CIT0088", "author": "Hallas C.", "volume": "78", "first-page": "277", "year": "1998", "journal-title": "Loboratory Investigations"}, {"key": "CIT0089", "DOI": "10.1002/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D", "doi-asserted-by": "publisher"}, {"key": "CIT0090", "author": "Greiner A.", "volume": "150", "first-page": "1583", "year": "1997", "journal-title": "American Journal of Pathology"}, {"key": "CIT0091", "DOI": "10.1038/sj.leu.2400908", "doi-asserted-by": "publisher"}, {"key": "CIT0092", "author": "Genta R. M", "volume": "8", "first-page": "2", "year": "1997", "journal-title": "Seminars in Gastrointestinal Disesases"}, {"key": "CIT0093", "DOI": "10.1016/S0016-5085(97)80009-1", "doi-asserted-by": "publisher"}, {"key": "CIT0094", "DOI": "10.1016/0140-6736(93)91408-E", "doi-asserted-by": "publisher"}, {"key": "CIT0095", "author": "Grciner A.", "volume": "70", "first-page": "572", "year": "1994", "journal-title": "Laboratory Investigations"}, {"key": "CIT0096", "DOI": "10.1136/jcp.44.6.515", "doi-asserted-by": "publisher"}, {"key": "CIT0097", "DOI": "10.1016/S0952-7915(96)80038-0", "doi-asserted-by": "publisher"}, {"key": "CIT0098", "DOI": "10.1111/j.1365-2133.1994.tb08560.x", "doi-asserted-by": "publisher"}, {"key": "CIT0099", "DOI": "10.1016/S0190-9622(97)80405-7", "doi-asserted-by": "publisher"}, {"key": "CIT0100", "DOI": "10.1023/A:1008282818705", "doi-asserted-by": "publisher"}, {"key": "CIT0101", "DOI": "10.1023/A:1008265829249", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "CIT0102", "first-page": "267b", "volume": "90", "author": "Roggero E.", "year": "1997", "journal-title": "Blood"}, {"key": "CIT0103", "DOI": "10.1016/S0016-5085(97)80005-4", "doi-asserted-by": "publisher"}, {"key": "CIT0104", "author": "Parsonnet J", "volume": "57", "first-page": "3620", "year": "1997", "journal-title": "Cancer Res"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.3109/10428199909145705", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 9, 10]], "date-time": "2018-09-10T13:57:14Z", "timestamp": 1536587834000}, "score": 50.695084, "issued": {"date-parts": [[1999, 1]]}, "references-count": 104, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[1999, 1]]}, "issue": "1-2"}, "alternative-id": ["10.3109/10428199909145705"], "URL": "http://dx.doi.org/10.3109/10428199909145705", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:23:23Z", "timestamp": 1575530603332}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "22", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2009, 11, 20]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Abstract 3939</jats:p>\n               <jats:p>Poster Board III-875</jats:p>\n               <jats:p>The available clinical information on MALT lymphoma is mostly based on retrospective series. In 2003 the International Extranodal Lymphoma Study Group launched the IELSG-19 study to compare Chlorambucil alone versus the combination of Chlorambucil and Rituximab. Because of the excellent initial recruitment, a third arm with Rituximab alone was later introduced. The study is still ongoing and at the end of July 2009, 403 patients (pts) of the 450 planned have entered. The Italian Lymphoma Intergroup and the French GELA group were the main contributors to this study together with Cancer Research UK, the Catalan Hematology Group and the Oncology Institute of Southern Switzerland.</jats:p>\n               <jats:p>All the MALT lymphoma pts with localized disease at any extranodal site who do not respond or are not suitable to local therapy, the H.pylori-negative gastric lymphomas or those who failed antibiotic therapy are eligible, as well as those with disseminated or multifocal MALT lymphoma. Histology review of all cases is underway.</jats:p>\n               <jats:p>A planned interim analysis was performed in April 2009 on the first 320 pts, 169 men (53%) and 151 women (47%); 292 pts (91%) had no previous treatment. The treatment was completed in in 86% of the 320 analysed pts, in 64% without dose changes or time delay. The primary MALT lymphoma site was the stomach in 138 pts (43%);182 pts (57%) had a non-gastric presentation. The most common non-gastric sites were the lungs (N=42, 13%), the ocular adnexa (N=32; 10%), the intestine (N=29; 9%), the salivary glands (N=26; 8%), and the skin (N=21; 7%). In 95 pts (30%) the lymphoma involved more than 1 extranodal site. Lymph node involvement was present in 118 pts (37%); 181 pts (58%) had localized disease (Ann Arbor stage I-II) while 129 (42%) had advanced stage. The ECOG performance status was 0 in 230 pts (74%). According to the international prognostic index (IPI) 190 pts (59%) had a low risk, 68 (21%) a low-intermediate risk, 54 (17%) an intermediate-high risk, and only 8 (2.5%) a high risk score. B-symptoms were present in 33 pts (11%) and LDH levels were higher than normal in 31 (10%).</jats:p>\n               <jats:p>The median age is 61 year (range, 26-81). At a median follow-up of 40 months, overall survival (OS), progression-free survival (PFS) and event-free survival (EFS) are 96%, 88%, and 62%, respectively.</jats:p>\n               <jats:p>Among the main clinical characteristics, the presence of B-symptoms, elevated LDH, more than one extranodal site, advanced stage, poorer performance and unfavourable IPI scores were significantly (p&lt;0.05) associated with shorter OS, PFS and EFS. The presence of lymph nodal involvement was significantly associated with shorter PFS and EFS but did not affect the OS. Patient younger than 60 years had longer OS and PFS but age had no effect on the EFS. Differently from previous series, there were no differences in outcome between pts with gastric and non-gastric localization; this finding is likely due to the fact that H. pylori-positive gastric MALT lymphoma pts still responding to antibiotics were excluded from the study.</jats:p>\n               <jats:p>This is by far the largest prospective study ever conducted in MALT lymphomas; further analyses are in progress.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures:</jats:title>\n                  <jats:p>Zucca: Mundipharma: Research Support; Johnson &amp; Johnson: Research Support; Roche: Research Support.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v114.22.3939.3939", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T16:47:06Z", "timestamp": 1570985226000}, "page": "3939-3939", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Interim Analysis of the IELSG-19 Randomised Study of Chlorambucil Alone Versus Chlorambucil Plus Rituximab Versus Rituximab Alone in Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma)."], "prefix": "10.1182", "volume": "114", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": [{"name": "IOSI - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland,"}]}, {"given": "Annarita", "family": "Conconi", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy,"}]}, {"given": "Maurizio", "family": "Martelli", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, University La Sapienza, Rome, Italy,"}]}, {"given": "Catherine", "family": "Thieblemont", "sequence": "additional", "affiliation": [{"name": "Hemato-Oncology, Hopital Saint-Louis, APHP - INSERM U 728 - Institut Universitaire d'Hematologie, Paris, France,"}]}, {"given": "Peter", "family": "Johnson", "sequence": "additional", "affiliation": [{"name": "Cancer Research UK Clinical Centre, Southampton General Hospital, United Kingdom,"}]}, {"given": "Armando Lopez", "family": "Guillermo", "sequence": "additional", "affiliation": [{"name": "Hospital Cli\u0301nic, Barcelona, Spain,"}]}, {"given": "Reda", "family": "Bouabdallah", "sequence": "additional", "affiliation": [{"name": "Institut Paoli-Calmettes, Marseille, France,"}]}, {"given": "Alessandra", "family": "Tucci", "sequence": "additional", "affiliation": [{"name": "Division of Hematology, Spedali Civili, Brescia, Italy,"}]}, {"given": "Umberto", "family": "Vitolo", "sequence": "additional", "affiliation": [{"name": "Hematology 2, AOU San Giovanni Battista, Torino, Italy,"}]}, {"given": "Bertrand", "family": "Coiffier", "sequence": "additional", "affiliation": [{"name": "Centre Hospitalier Lyon-Sud, Pierre-Be\u0301nite, France,"}]}, {"given": "Liliana", "family": "Devizzi", "sequence": "additional", "affiliation": [{"name": "Istituto Nazionale Tumori, Milano, Italy,"}]}, {"given": "Fabrice", "family": "Jardin", "sequence": "additional", "affiliation": [{"name": "Hematology, INSERM U918, Centre Henri Becquerel, Rouen, France,"}]}, {"given": "Catherine", "family": "Sebban", "sequence": "additional", "affiliation": [{"name": "Hematology, centre Le\u0301on Be\u0301rard, Lyon, France,"}]}, {"given": "Graziella", "family": "Pinotti", "sequence": "additional", "affiliation": [{"name": "UO Oncologia Medica, Ospedale di Circolo Fondazione Macchi, Varese,"}]}, {"given": "Franck", "family": "Morschhauser", "sequence": "additional", "affiliation": [{"name": "Hematology, Centre Hospitalier Universitaire, Lille, France,"}]}, {"given": "Ruth", "family": "Pettengell", "sequence": "additional", "affiliation": [{"name": "St Georges University of London, London, United Kingdom,"}]}, {"given": "Andre\u0301", "family": "Bosly", "sequence": "additional", "affiliation": [{"name": "Hematology, UCL Mont-Godinne, Yvoir, Belgium,"}]}, {"given": "Emilio", "family": "Montserrat", "sequence": "additional", "affiliation": [{"name": "Hospital Cli\u0301nic, Barcelona, Spain,"}]}, {"given": "Monica", "family": "Bellei", "sequence": "additional", "affiliation": [{"name": "Dipartimento di Oncologia ed Ematologia, Universita' di Modena e Reggio Emilia, Modena, Italy,"}]}, {"given": "Stefano A.", "family": "Pileri", "sequence": "additional", "affiliation": [{"name": "Department of Hematology and Oncological Sciences, University of Bologna, Bologna, Italy,"}]}, {"given": "Christiane", "family": "Copie-Bergman", "sequence": "additional", "affiliation": [{"name": "Pathology Department, Hopital Henri Mondor, Paris Creteil Cedex, France,"}]}, {"given": "Elias", "family": "Campo", "sequence": "additional", "affiliation": [{"name": "Anatomia Patologica, Hospital Clinic Provincial, Barcelona, Spain,"}]}, {"given": "Andrew", "family": "Jack", "sequence": "additional", "affiliation": [{"name": "St James's Institute of Oncology, HMDS, Leeds, United Kingdom,"}]}, {"given": "Luca", "family": "Mazzucchelli", "sequence": "additional", "affiliation": [{"name": "Istituto Cantonale di Patologia (ICPL), Locarno, Switzerland,"}]}, {"given": "Irene", "family": "Floriani", "sequence": "additional", "affiliation": [{"name": "Department of Oncology, Istituto di Ricerche Farmacologiche, Milan, Italy,"}]}, {"given": "Daniela", "family": "Garavaglia", "sequence": "additional", "affiliation": [{"name": "Department of Oncology, Istituto di Ricerche Farmacologiche, Milan, Italy,"}]}, {"given": "Valter", "family": "Torri", "sequence": "additional", "affiliation": [{"name": "Department of Oncology, Istituto di Ricerche Farmacologiche, Milan, Italy,"}]}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": [{"name": "IOSI - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland,"}]}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": [{"name": "Hematology, European Institute of Oncology, Milan, Italy"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/114/22/3939/76143/Interim-Analysis-of-the-IELSG19-Randomised-Study", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/114/22/3939/76143/Interim-Analysis-of-the-IELSG19-Randomised-Study", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 17]], "date-time": "2019-11-17T19:55:32Z", "timestamp": 1574020532000}, "score": 47.307507, "issued": {"date-parts": [[2009, 11, 20]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 11, 20]]}, "issue": "22"}, "URL": "http://dx.doi.org/10.1182/blood.v114.22.3939.3939", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T19:21:55Z", "timestamp": 1574709715079}, "reference-count": 40, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 56, "content-version": "tdm"}], "funder": [{"name": "Mayo CCaTS", "award": ["UL1TRZZZ135"]}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hematol Oncol"], "published-print": {"date-parts": [[2016, 12]]}, "DOI": "10.1002/hon.2243", "type": "journal-article", "created": {"date-parts": [[2015, 7, 8]], "date-time": "2015-07-08T03:05:52Z", "timestamp": 1436324752000}, "page": "177-183", "source": "Crossref", "is-referenced-by-count": 13, "title": ["A retrospective international study on primary extranodal marginal zone lymphoma of the lung (BALT lymphoma) on behalf of International Extranodal Lymphoma Study Group (IELSG)"], "prefix": "10.1002", "volume": "34", "author": [{"given": "Simona", "family": "Sammassimo", "sequence": "first", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Giancarlo", "family": "Pruneri", "sequence": "additional", "affiliation": [{"name": "Pathology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Giovanna", "family": "Andreola", "sequence": "additional", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Juan", "family": "Montoro", "sequence": "additional", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Sara", "family": "Steffanoni", "sequence": "additional", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Grzegorz S.", "family": "Nowakowski", "sequence": "additional", "affiliation": [{"name": "Mayo Clinic; Rochester MN USA"}]}, {"given": "Sara", "family": "Gandini", "sequence": "additional", "affiliation": [{"name": "Epidemiology and Biostatistics Department; European Institute of Oncology; Milan Italy"}]}, {"given": "Mara", "family": "Negri", "sequence": "additional", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}, {"given": "Thomas M.", "family": "Habermann", "sequence": "additional", "affiliation": [{"name": "Mayo Clinic; Rochester MN USA"}]}, {"given": "Markus", "family": "Raderer", "sequence": "additional", "affiliation": [{"name": "Medical University; Vienna Austria"}]}, {"given": "Zhi-Ming", "family": "Li", "sequence": "additional", "affiliation": [{"name": "Sun Yat-Sen University Cancer Center; Guangzhou China"}]}, {"given": "Pier Luigi", "family": "Zinzani", "sequence": "additional", "affiliation": [{"name": "Policlinico Sant'Orsola; Bologna Italy"}]}, {"given": "Patrick", "family": "Adam", "sequence": "additional", "affiliation": [{"name": "Pathologisches Institut der Universit\u00e4t; W\u00fcrzburg Germany"}]}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": [{"name": "IOSI; Bellinzona Switzerland"}]}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": [{"name": "Haematoncology Division; European Institute of Oncology; Milan Italy"}]}], "member": "311", "published-online": {"date-parts": [[2015, 7, 7]]}, "reference": [{"key": "10.1002/hon.2243-BIB0001|hon2243-cit-0001", "doi-asserted-by": "crossref", "first-page": "442", "DOI": "10.1111/j.1365-2559.1987.tb02654.x", "article-title": "Malignant lymphoma of mucosa-associated lymphoid tissue", "volume": "11", "author": "Isaacson", "year": "1987", "journal-title": "Histopathology"}, {"issue": "2", "key": "10.1002/hon.2243-BIB0002|hon2243-cit-0002", "first-page": "119", "article-title": "Structure and function of bronchus-associated lymphoid tissue (BALT)", "volume": "9", "author": "Sminia", "year": "1989", "journal-title": "Crit Rev Immunol"}, {"key": "10.1002/hon.2243-BIB0003|hon2243-cit-0003", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/S0092-8674(00)80957-5", "article-title": "Bcl10 is involved in t (1; 14) (p22; q32) of MALT B cell lymphoma and mutated in multiple tumour type", "volume": "96", "author": "Willis", "year": "1999", "journal-title": "Cell"}, {"key": "10.1002/hon.2243-BIB0004|hon2243-cit-0004", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1016/0165-4608(92)90130-Z", "article-title": "Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue", "volume": "58", "author": "Wotherspoon", "year": "1992", "journal-title": "Cancer Genet Cytogenet"}, {"key": "10.1002/hon.2243-BIB0005|hon2243-cit-0005", "first-page": "2000", "article-title": "Trisomy 3 in low-grade B cell lymphomas of mucosa-associated lymphoid tissue", "volume": "85", "author": "Wotherspoon", "year": "1995", "journal-title": "Blood"}, {"key": "10.1002/hon.2243-BIB0006|hon2243-cit-0006", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1378/chest.103.1.201", "article-title": "Primary pulmonary lymphomas. A clinical study of 70 cases in non-immuno-compromised patients", "volume": "103", "author": "Cordier", "year": "1993", "journal-title": "Chest"}, {"key": "10.1002/hon.2243-BIB0007|hon2243-cit-0007", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.1365-2559.1990.tb01157.x", "article-title": "Primary lymphomas of the lung: morphological, immunohistochemical and clinical features", "volume": "16", "author": "Li", "year": "1990", "journal-title": "Histopathology"}, {"key": "10.1002/hon.2243-BIB0008|hon2243-cit-0008", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1093/jnci/djh102", "article-title": "Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas", "volume": "96", "author": "Ferreri", "year": "2004", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/hon.2243-BIB0009|hon2243-cit-0009", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0046-8177(00)80233-6", "article-title": "Eradication of Borrelia Burgdorferi infection in primary marginal zone B cell lymphoma of skin", "volume": "31", "author": "Roggero", "year": "2000", "journal-title": "Hum Pathol"}, {"key": "10.1002/hon.2243-BIB0010|hon2243-cit-0010", "doi-asserted-by": "crossref", "first-page": "819", "DOI": "10.1097/00000478-199109000-00001", "article-title": "Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue", "volume": "15", "author": "Isaacson", "year": "1991", "journal-title": "Am J Surg Pathol"}, {"issue": "6", "key": "10.1002/hon.2243-BIB0011|hon2243-cit-0011", "doi-asserted-by": "crossref", "first-page": "804", "DOI": "10.1111/bjh.12703", "article-title": "Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe", "volume": "164", "author": "Adam", "year": "2014", "journal-title": "Br J Haematol"}, {"key": "10.1002/hon.2243-BIB0012|hon2243-cit-0012", "doi-asserted-by": "crossref", "first-page": "510", "DOI": "10.1093/jjco/hyh095", "article-title": "Primary pulmonary non-Hodgkin's lymphoma", "volume": "34", "author": "Kim", "year": "2004", "journal-title": "Jpn J Clin Oncol"}, {"key": "10.1002/hon.2243-BIB0013|hon2243-cit-0013", "doi-asserted-by": "crossref", "first-page": "993", "DOI": "10.1016/S0003-4975(99)01535-0", "article-title": "Primary non-Hodgkin's lymphoma of the lung", "volume": "69", "author": "Ferraro", "year": "2000", "journal-title": "Thorac Surg"}, {"key": "10.1002/hon.2243-BIB0014|hon2243-cit-0014", "first-page": "307", "article-title": "Primary pulmonary lymphoma", "volume": "26", "author": "Habermann", "year": "1999", "journal-title": "Semin Oncol"}, {"key": "10.1002/hon.2243-BIB0015|hon2243-cit-0015", "doi-asserted-by": "crossref", "first-page": "750", "DOI": "10.1183/09031936.02.00404102", "article-title": "Primary pulmonary lymphoma", "volume": "20", "author": "Cadranel", "year": "2002", "journal-title": "Eur Respir"}, {"key": "10.1002/hon.2243-BIB0016|hon2243-cit-0016", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1111/j.1365-2559.1988.tb02000.x", "article-title": "Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia", "volume": "13", "author": "Addis", "year": "1988", "journal-title": "Histopathology"}, {"key": "10.1002/hon.2243-BIB0017|hon2243-cit-0017", "doi-asserted-by": "crossref", "first-page": "1248", "DOI": "10.1016/j.athoracsur.2005.04.014", "article-title": "Primary pulmonary lymphoma", "volume": "80", "author": "Graham", "year": "2005", "journal-title": "Ann Thorac Surg"}, {"key": "10.1002/hon.2243-BIB0018|hon2243-cit-0018", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.1016/j.athoracsur.2006.08.026", "article-title": "Role of surgery in the treatment of primary pulmonary B-cell lymphoma", "volume": "83", "author": "Eynden", "year": "2007", "journal-title": "Ann Thorac Surg"}, {"key": "10.1002/hon.2243-BIB0019|hon2243-cit-0019", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1097/00029330-200704020-00007", "article-title": "Diagnosis and treatment of pulmonary mucosa-associated lymphoid tissue lymphoma", "volume": "20", "author": "Xu", "year": "2007", "journal-title": "Chin Med J"}, {"key": "10.1002/hon.2243-BIB0020|hon2243-cit-0020", "doi-asserted-by": "crossref", "first-page": "S1", "DOI": "10.1038/modpathol.2012.177", "article-title": "Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP Long Course", "volume": "26", "author": "Swerdlow", "year": "2013", "journal-title": "Mod Pathol"}, {"key": "10.1002/hon.2243-BIB0021|hon2243-cit-0021", "doi-asserted-by": "crossref", "first-page": "207", "DOI": "10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6", "article-title": "Reporting results of cancer", "volume": "47", "author": "Miller", "year": "1981", "journal-title": "Cancer"}, {"issue": "282", "key": "10.1002/hon.2243-BIB0022|hon2243-cit-0022", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1080/01621459.1958.10501452", "article-title": "Nonparametric estimation from incomplete observations", "volume": "53", "author": "Kaplan", "year": "1958", "journal-title": "J Am Stat Assoc"}, {"key": "10.1002/hon.2243-BIB0023|hon2243-cit-0023", "author": "Altman", "year": "1991", "volume-title": "Practical Statistics for Medical Research"}, {"key": "10.1002/hon.2243-BIB0024|hon2243-cit-0024", "doi-asserted-by": "crossref", "first-page": "1059", "DOI": "10.1081/CNV-120005924", "article-title": "Low-grade B-cell bronchial associated lymphoid tissue (BALT) lymphoma", "volume": "20", "author": "Ahmed", "year": "2002", "journal-title": "Can Inves"}, {"key": "10.1002/hon.2243-BIB0025|hon2243-cit-0025", "doi-asserted-by": "crossref", "first-page": "252", "DOI": "10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#", "article-title": "Occurrence and prognosis of extranodal lymphomas", "volume": "29", "author": "Freeman", "year": "1972", "journal-title": "Cancer"}, {"key": "10.1002/hon.2243-BIB0026|hon2243-cit-0026", "doi-asserted-by": "crossref", "first-page": "492", "DOI": "10.1016/S0025-6196(12)60199-2", "article-title": "Rare pulmonary neoplasm", "volume": "68", "author": "Miller", "year": "1993", "journal-title": "Mayo Clin Proc"}, {"issue": "8", "key": "10.1002/hon.2243-BIB0027|hon2243-cit-0027", "doi-asserted-by": "crossref", "first-page": "997", "DOI": "10.1097/00000478-200108000-00003", "article-title": "Pathologic and clinical features of primary pulmonary extranodal marginal zone B-cell lymphoma of MALT-type", "volume": "25", "author": "Kurtin", "year": "2001", "journal-title": "Am J Surg Pathol"}, {"key": "10.1002/hon.2243-BIB0028|hon2243-cit-0028", "doi-asserted-by": "crossref", "first-page": "637", "DOI": "10.1023/A:1008396618983", "article-title": "Gastric MALT lymphoma: from concept to cure", "volume": "10", "author": "Isaacson", "year": "1999", "journal-title": "Ann Oncol"}, {"key": "10.1002/hon.2243-BIB0029|hon2243-cit-0029", "doi-asserted-by": "crossref", "first-page": "766", "DOI": "10.1016/S0046-8177(88)80259-4", "article-title": "Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis", "volume": "19", "author": "Hyjek", "year": "1988", "journal-title": "Hum Pathol"}, {"key": "10.1002/hon.2243-BIB0030|hon2243-cit-0030", "doi-asserted-by": "crossref", "first-page": "229", "DOI": "10.1002/path.1711690209", "article-title": "Bronchus-associated lymphoid tissue (BALT) in human fetal and infant lung", "volume": "169", "author": "Gould", "year": "1993", "journal-title": "J Pathol"}, {"key": "10.1002/hon.2243-BIB0031|hon2243-cit-0031", "doi-asserted-by": "crossref", "first-page": "119", "DOI": "10.1016/0167-5699(92)90106-H", "article-title": "Is BALT a major component of the human lung immune system?", "volume": "13", "author": "Pabst", "year": "1992", "journal-title": "Immunol Today"}, {"key": "10.1002/hon.2243-BIB0032|hon2243-cit-0032", "doi-asserted-by": "crossref", "first-page": "1024", "DOI": "10.1016/S0046-8177(83)80258-5", "article-title": "Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: a study of 161 patients", "volume": "14", "author": "Koss", "year": "1983", "journal-title": "Hum Pathol"}, {"issue": "6", "key": "10.1002/hon.2243-BIB0033|hon2243-cit-0033", "doi-asserted-by": "crossref", "first-page": "431", "DOI": "10.1016/j.semcancer.2013.09.004", "article-title": "Marginal zone lymphoma and infectious agents", "volume": "23", "author": "Ferreri", "year": "2013", "journal-title": "Semin Cancer Biol"}, {"issue": "2", "key": "10.1002/hon.2243-BIB0034|hon2243-cit-0034", "doi-asserted-by": "crossref", "first-page": "290", "DOI": "10.1007/s00292-008-1068-1", "article-title": "The spectrum of microbiological agents causing pulmonary MALT-type lymphomas. A 16S rRNA-based analysis of microbial diversity", "volume": "29", "author": "Adam", "year": "2008", "journal-title": "Pathologe"}, {"key": "10.1002/hon.2243-BIB0035|hon2243-cit-0035", "doi-asserted-by": "crossref", "first-page": "1320", "DOI": "10.1016/j.ejca.2004.02.006", "article-title": "Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease", "volume": "40", "author": "Ahmed", "year": "2004", "journal-title": "Eur J Cancer"}, {"key": "10.1002/hon.2243-BIB0036|hon2243-cit-0036", "doi-asserted-by": "crossref", "first-page": "2227", "DOI": "10.1016/j.rmed.2006.11.028", "article-title": "A patient with endobronchial BALT lymphoma successfully treated with radiotherapy", "volume": "101", "author": "Hashemi", "year": "2007", "journal-title": "Respir Med"}, {"key": "10.1002/hon.2243-BIB0037|hon2243-cit-0037", "doi-asserted-by": "crossref", "first-page": "2524", "DOI": "10.1200/JCO.1995.13.10.2524", "article-title": "Efficacy of single agent chemotherapy in low grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression", "volume": "13", "author": "Hammel", "year": "1995", "journal-title": "J Clin Oncol"}, {"key": "10.1002/hon.2243-BIB0038|hon2243-cit-0038", "doi-asserted-by": "crossref", "first-page": "2190", "DOI": "10.1002/cncr.20237", "article-title": "Fludarabine containing chemotherapy as frontline treatment of non gastrointestinal mucosa-associated lymphoid tissue lymphoma", "volume": "100", "author": "Zinzani", "year": "2004", "journal-title": "Cancer"}, {"key": "10.1002/hon.2243-BIB0039|hon2243-cit-0039", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1200/JCO.2011.40.6272", "article-title": "Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 randomized study", "volume": "31", "author": "Zucca", "year": "2013", "journal-title": "J Clin Oncol"}, {"key": "10.1002/hon.2243-BIB0040|hon2243-cit-0040", "doi-asserted-by": "crossref", "first-page": "1203", "DOI": "10.1016/S0140-6736(12)61763-2", "article-title": "Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial", "volume": "381", "author": "Rummel", "year": "2013", "journal-title": "Lancet"}], "container-title": ["Hematological Oncology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2243", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.2243", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/hon.2243/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 8, 28]], "date-time": "2019-08-28T02:28:42Z", "timestamp": 1566959322000}, "score": 46.289482, "subtitle": ["Retrospective analysis on BALT lymphoma"], "issued": {"date-parts": [[2015, 7, 7]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2016, 12]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/hon.2243", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0278-0232"], "issn-type": [{"value": "0278-0232", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T23:53:47Z", "timestamp": 1576799627098}, "reference-count": 26, "publisher": "American Society of Clinical Oncology (ASCO)", "issue": "17", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["JCO"], "published-print": {"date-parts": [[2017, 6, 10]]}, "abstract": "<jats:sec><jats:title>Purpose</jats:title><jats:p> There is no consensus on the optimal systemic treatment of patients with extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue. The IELSG-19 phase III study, to our knowledge, was the first such study to address the question of first-line treatment in a randomized trial. </jats:p></jats:sec><jats:sec><jats:title>Patients and Methods</jats:title><jats:p> Eligible patients were initially randomly assigned (1:1 ratio) to receive either chlorambucil monotherapy (6 mg/m<jats:sup>2</jats:sup>/d orally on weeks 1 to 6, 9 to 10, 13 to 14, 17 to 18, and 21 to 22) or a combination of chlorambucil (same schedule as above) and rituximab (375 mg/m<jats:sup>2</jats:sup> intravenously on day 1 of weeks 1, 2, 3, 4, 9, 13, 17, and 21). After the planned enrollment of 252 patients, the protocol was amended to continue with a three-arm design (1:1:6 ratio), with a new arm that included rituximab alone (same schedule as the combination arm) and with a final sample size of 454 patients. The main end point was event-free survival (EFS). Analysis of chlorambucil versus the combination arm was performed and reported separately before any analysis of the third arm. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> At a median follow-up of 7.4 years, addition of rituximab to chlorambucil led to significantly better EFS (hazard ratio, 0.54; 95% CI, 0.38 to 0.77). EFS at 5 years was 51% (95% CI, 42 to 60) with chlorambucil alone, 50% (95% CI, 42 to 59) with rituximab alone, and 68% (95% CI, 60 to 76) with the combination ( P = .0009). Progression-free survival was also significantly better with the combination ( P = .0119). Five-year overall survival was approximately 90% in each arm. All treatments were well tolerated. No unexpected toxicities were recorded. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> Rituximab in combination with chlorambucil demonstrated superior efficacy in mucosa-associated lymphoid tissue lymphoma; however, improvements in EFS and progression-free survival did not translate into longer overall survival. </jats:p></jats:sec>", "DOI": "10.1200/jco.2016.70.6994", "type": "journal-article", "created": {"date-parts": [[2017, 3, 29]], "date-time": "2017-03-29T19:57:36Z", "timestamp": 1490817456000}, "page": "1905-1912", "source": "Crossref", "is-referenced-by-count": 39, "title": ["Final Results of the IELSG-19 Randomized Trial of Mucosa-Associated Lymphoid Tissue Lymphoma: Improved Event-Free and Progression-Free Survival With Rituximab Plus Chlorambucil Versus Either Chlorambucil or Rituximab Monotherapy"], "prefix": "10.1200", "volume": "35", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Annarita", "family": "Conconi", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Reda", "family": "Bouabdallah", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Alessandra", "family": "Tucci", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Umberto", "family": "Vitolo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Maurizio", "family": "Martelli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Ruth", "family": "Pettengell", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Gilles", "family": "Salles", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Catherine", "family": "Sebban", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Armando Lopez", "family": "Guillermo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Graziella", "family": "Pinotti", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Liliana", "family": "Devizzi", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Franck", "family": "Morschhauser", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Herv\u00e9", "family": "Tilly", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Valter", "family": "Torri", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Stefan", "family": "Hohaus", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Andr\u00e9s J.M.", "family": "Ferreri", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Pierre", "family": "Zach\u00e9e", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Andr\u00e9", "family": "Bosly", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Corinne", "family": "Haioun", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Caterina", "family": "Stelitano", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Monica", "family": "Bellei", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Maurilio", "family": "Ponzoni", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Anne", "family": "Moreau", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Andrew", "family": "Jack", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Elias", "family": "Campo", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Luca", "family": "Mazzucchelli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Peter", "family": "Johnson", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}, {"given": "Catherine", "family": "Thieblemont", "sequence": "additional", "affiliation": [{"name": "Emanuele Zucca and Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona; Luca Mazzucchelli, Cantonal Institute of Pathology, Locarno, Switzerland; Annarita Conconi, Ospedale degli Infermi, Biella; Giovanni Martinelli, European Institute of Oncology; Liliana Devizzi, Fondazione Istituto Nazionale Tumori; Valter Torri, Mario Negri Institute; Andr\u00e9s J.M. Ferreri, San Raffaele Scientific Institute; Maurilio Ponzoni, San Raffaele Hospital, Milan; Alessandra Tucci, Spedali Civili, Brescia;..."}]}], "member": "233", "container-title": ["Journal of Clinical Oncology"], "language": "en", "link": [{"URL": "http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.70.6994", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:31:25Z", "timestamp": 1574886685000}, "score": 45.04017, "issued": {"date-parts": [[2017, 6, 10]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2017, 6, 10]]}, "issue": "17"}, "alternative-id": ["10.1200/JCO.2016.70.6994"], "URL": "http://dx.doi.org/10.1200/jco.2016.70.6994", "ISSN": ["0732-183X", "1527-7755"], "issn-type": [{"value": "0732-183X", "type": "print"}, {"value": "1527-7755", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T22:12:16Z", "timestamp": 1575238336879}, "publisher-location": "Unitec House, 2 Albert Place, London N3 1QB, UK", "reference-count": 37, "publisher": "Future Medicine Ltd", "isbn-type": [{"value": "9781780841717", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 6]]}, "DOI": "10.2217/ebo.13.26", "type": "other", "created": {"date-parts": [[2013, 6, 20]], "date-time": "2013-06-20T15:22:33Z", "timestamp": 1371741753000}, "page": "250-262", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MALT lymphoma: extranodal marginal zone B-cell lymphoma of MALT"], "prefix": "10.2217", "author": [{"given": "Anastasios", "family": "Stathis", "sequence": "first", "affiliation": []}, {"given": "Francesco", "family": "Bertoni", "sequence": "additional", "affiliation": []}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": []}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": []}], "member": "1057", "published-online": {"date-parts": [[2013, 6, 20]]}, "reference": [{"key": "ch15-bid.1", "unstructured": "Isaacson PG , Chott A , Nakamura Set al.Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In:WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues.Swerdlow S, Campo E, Harris NLet al.(Eds). IARC, Lyon, France , 214 \u2013 217 (2008) ."}, {"key": "ch15-bid.2", "unstructured": "Campo E , Pileri SA , Jaffe ESet al.Nodal marginal zone lymphoma. In:WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues.Swerdlow S, Campo E, Harris NLet al.(Eds). IARC, Lyon, France , 218 \u2013 219 (2008) ."}, {"key": "ch15-bid.3", "unstructured": "Isaacson PG , Piris MA , Berger Fet al.Splenic B-cell marginal zone lymphoma. In:WHO Classification of Tumours of Haemopoietic and Lymphoid Tissues.Swerdlow S, Campo E, Harris NLet al.(Eds). IARC, Lyon, France 185 \u2013 187 (2008) ."}, {"key": "ch15-bid.4", "DOI": "10.1056/NEJM199405053301803", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.5", "DOI": "10.1016/0140-6736(91)92035-Z", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.6", "DOI": "10.1002/(SICI)1097-0142(19970101)79:1<3::AID-CNCR2>3.0.CO;2-P", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.7", "DOI": "10.1056/NEJM199803193381205", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.8", "DOI": "10.1002/(SICI)1096-9896(199602)178:2<122::AID-PATH486>3.0.CO;2-D", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.9", "DOI": "10.1111/j.1365-2141.2006.06444.x", "doi-asserted-by": "publisher"}, {"issue": "12", "key": "ch15-bid.10", "first-page": "1134", "volume": "25", "author": "Bertoni F", "year": "2011", "journal-title": "Oncology (Williston Park)."}, {"key": "ch15-bid.11", "DOI": "10.1016/0140-6736(93)91409-F", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.12", "DOI": "10.1016/S0140-6736(95)90113-2", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.13", "DOI": "10.7326/0003-4819-122-10-199505150-00006", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.14", "DOI": "10.3109/10428199709050889", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.15", "DOI": "10.1200/JCO.2005.02.3903", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.16", "DOI": "10.1093/annonc/mdn760", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.17", "DOI": "10.1136/gutjnl-2011-300495", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.18", "DOI": "10.1200/JCO.2011.41.4466", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.19", "DOI": "10.1016/j.hoc.2008.07.011", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.20", "DOI": "10.1182/blood-2010-01-264275", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.21", "author": "Dreyling M", "year": "2013", "journal-title": "Ann. Oncol."}, {"key": "ch15-bid.22", "DOI": "10.1111/j.1365-2559.2012.04289.x", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "ch15-bid.23", "doi-asserted-by": "crossref", "first-page": "1624", "DOI": "10.1200/JCO.1997.15.4.1624", "volume": "15", "author": "Thieblemont C", "year": "1997", "journal-title": "J. Clin. Oncol."}, {"key": "ch15-bid.24", "author": "Franceschetti S", "volume": "120", "year": "2012", "journal-title": "Blood (ASH Annual Meeting Abstracts)"}, {"key": "ch15-bid.25", "DOI": "10.1182/blood-2002-04-1279", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.26", "DOI": "10.1517/14656566.2010.497141", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.27", "DOI": "10.1136/gut.2010.224949", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.28", "DOI": "10.1111/bjh.12078", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.29", "DOI": "10.1002/cncr.22326", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.30", "DOI": "10.1136/gut.2005.083022", "doi-asserted-by": "publisher"}, {"issue": "5", "key": "ch15-bid.31", "doi-asserted-by": "crossref", "first-page": "1916", "DOI": "10.1200/JCO.1998.16.5.1916", "volume": "16", "author": "Schechter NR", "year": "1998", "journal-title": "J. Clin. Oncol."}, {"key": "ch15-bid.32", "DOI": "10.1200/JCO.2003.06.085", "doi-asserted-by": "publisher"}, {"issue": "10", "key": "ch15-bid.33", "doi-asserted-by": "crossref", "first-page": "2524", "DOI": "10.1200/JCO.1995.13.10.2524", "volume": "13", "author": "Hammel P", "year": "1995", "journal-title": "J. Clin. Oncol."}, {"key": "ch15-bid.34", "DOI": "10.1200/JCO.2002.05.117", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.35", "DOI": "10.1093/annonc/mdg492", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.36", "DOI": "10.1200/JCO.2005.08.128", "doi-asserted-by": "publisher"}, {"key": "ch15-bid.37", "DOI": "10.1200/JCO.2011.40.6272", "doi-asserted-by": "publisher"}], "container-title": ["Non-Hodgkin Lymphomas: Advanced Diagnostics & Personalized Therapies"], "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/ebo.13.26", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T09:49:42Z", "timestamp": 1574243382000}, "score": 44.782455, "issued": {"date-parts": [[2013, 6]]}, "ISBN": ["9781780841717"], "references-count": 37, "alternative-id": ["10.2217/ebo.13.26", "10.2217/9781780841717"], "URL": "http://dx.doi.org/10.2217/ebo.13.26", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T00:04:19Z", "timestamp": 1575504259751}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 9, 1]], "date-time": "2019-09-01T00:00:00Z", "timestamp": 1567296000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Lymphoma Myeloma and Leukemia"], "published-print": {"date-parts": [[2019, 9]]}, "DOI": "10.1016/j.clml.2019.07.434", "type": "journal-article", "created": {"date-parts": [[2019, 8, 28]], "date-time": "2019-08-28T17:31:09Z", "timestamp": 1567013469000}, "page": "S97-S99", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Marginal Zone Lymphomas"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Clinical Lymphoma Myeloma and Leukemia"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S215226501931208X?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S215226501931208X?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 28]], "date-time": "2019-08-28T20:35:50Z", "timestamp": 1567024550000}, "score": 44.267082, "issued": {"date-parts": [[2019, 9]]}, "references-count": 0, "alternative-id": ["S215226501931208X"], "URL": "http://dx.doi.org/10.1016/j.clml.2019.07.434", "ISSN": ["2152-2650"], "issn-type": [{"value": "2152-2650", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T21:41:17Z", "timestamp": 1574372477915}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "Supplement 4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Annals of Oncology"], "published-print": {"date-parts": [[2008, 6, 1]]}, "DOI": "10.1093/annonc/mdn204", "type": "journal-article", "created": {"date-parts": [[2008, 6, 2]], "date-time": "2008-06-02T08:37:45Z", "timestamp": 1212395865000}, "page": "iv77-iv80", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Extranodal lymphoma: a reappraisal"], "prefix": "10.1093", "volume": "19", "author": [{"given": "E.", "family": "Zucca", "sequence": "first", "affiliation": []}], "member": "286", "container-title": ["Annals of Oncology"], "language": "en", "link": [{"URL": "http://academic.oup.com/annonc/article-pdf/19/suppl_4/iv77/354666/mdn204.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 22]], "date-time": "2017-08-22T17:49:29Z", "timestamp": 1503424169000}, "score": 40.853127, "issued": {"date-parts": [[2008, 6, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2008, 6, 1]]}, "issue": "Supplement 4"}, "URL": "http://dx.doi.org/10.1093/annonc/mdn204", "ISSN": ["0923-7534", "1569-8041"], "issn-type": [{"value": "0923-7534", "type": "print"}, {"value": "1569-8041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 3]], "date-time": "2019-12-03T23:04:22Z", "timestamp": 1575414262170}, "publisher-location": "Cambridge", "edition-number": "2", "reference-count": 0, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780511862472", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1017/cbo9780511862472.009", "type": "book-chapter", "created": {"date-parts": [[2013, 12, 18]], "date-time": "2013-12-18T06:00:42Z", "timestamp": 1387346442000}, "page": "104-120", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MALT and other marginal zone lymphomas"], "prefix": "10.1017", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": []}, {"given": "Francesco", "family": "Bertoni", "sequence": "additional", "affiliation": []}], "member": "56", "container-title": ["Lymphoma"], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T00:09:43Z", "timestamp": 1523578183000}, "score": 40.67054, "editor": [{"given": "Robert", "family": "Marcus", "sequence": "additional", "affiliation": []}, {"given": "John W.", "family": "Sweetenham", "sequence": "additional", "affiliation": []}, {"given": "Michael E.", "family": "Williams", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[null]]}, "ISBN": ["9780511862472"], "references-count": 0, "URL": "http://dx.doi.org/10.1017/cbo9780511862472.009"}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T07:50:59Z", "timestamp": 1574322659674}, "reference-count": 9, "publisher": "Informa UK Limited", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2009, 1]]}, "DOI": "10.1080/10428190903186494", "type": "journal-article", "created": {"date-parts": [[2009, 9, 15]], "date-time": "2009-09-15T22:30:38Z", "timestamp": 1253053838000}, "page": "1709-1711", "source": "Crossref", "is-referenced-by-count": 7, "title": ["The simplified mantle cell lymphoma international prognostic index predicts overall survival but not progression-free survival in patients with mantle cell lymphoma treated with fludarabine and cyclophosphamide\u00b1rituximab: results of a randomized phase II trial"], "prefix": "10.1080", "volume": "50", "author": [{"given": "Heather E.", "family": "Eve", "sequence": "first", "affiliation": []}, {"given": "Jo", "family": "Gambell", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Smith", "sequence": "additional", "affiliation": []}, {"given": "Wendi", "family": "Qian", "sequence": "additional", "affiliation": []}, {"given": "Simon A. J.", "family": "Rule", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 10, 8]]}, "reference": [{"key": "CIT0001", "DOI": "10.1056/NEJM199309303291402", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1182/blood-2003-12-4434", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.1182/blood-2007-06-095331", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1182/blood-2008-06-160259", "doi-asserted-by": "publisher"}, {"issue": "4", "key": "CIT0005", "first-page": "439", "volume": "19", "author": "Terol M J", "year": "2008", "journal-title": "Ann Oncol"}, {"key": "CIT0006", "author": "Salek D", "volume": "112", "first-page": "3745", "year": "2008", "journal-title": "Blood"}, {"key": "CIT0007", "author": "Pan L", "volume": "112", "first-page": "1143", "year": "2008", "journal-title": "Blood"}, {"key": "CIT0008", "DOI": "10.1182/blood-2008-05-155507", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.1200/JCO.2005.01.1825", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/10428190903186494", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T16:02:29Z", "timestamp": 1481817749000}, "score": 40.0904, "issued": {"date-parts": [[2009, 1]]}, "references-count": 9, "journal-issue": {"published-online": {"date-parts": [[2009, 10, 8]]}, "published-print": {"date-parts": [[2009, 1]]}, "issue": "10"}, "alternative-id": ["10.1080/10428190903186494"], "URL": "http://dx.doi.org/10.1080/10428190903186494", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T16:07:01Z", "timestamp": 1574870821269}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 9, 1]], "date-time": "2018-09-01T00:00:00Z", "timestamp": 1535760000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Lymphoma Myeloma and Leukemia"], "published-print": {"date-parts": [[2018, 9]]}, "DOI": "10.1016/j.clml.2018.06.068", "type": "journal-article", "created": {"date-parts": [[2018, 8, 29]], "date-time": "2018-08-29T16:21:30Z", "timestamp": 1535559690000}, "page": "S93-S94", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Marginal Zone Lymphomas"], "prefix": "10.1016", "volume": "18", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Clinical Lymphoma Myeloma and Leukemia"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S2152265018307249?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S2152265018307249?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 10, 25]], "date-time": "2018-10-25T18:39:15Z", "timestamp": 1540492755000}, "score": 40.02684, "issued": {"date-parts": [[2018, 9]]}, "references-count": 0, "alternative-id": ["S2152265018307249"], "URL": "http://dx.doi.org/10.1016/j.clml.2018.06.068", "ISSN": ["2152-2650"], "issn-type": [{"value": "2152-2650", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T04:27:43Z", "timestamp": 1576816063697}, "edition-number": "1", "reference-count": 21, "publisher": "Cambridge University Press", "isbn-type": [{"value": "9780521865449", "type": "print"}, {"value": "9780511663369", "type": "electronic"}], "license": [{"URL": "https://www.cambridge.org/core/terms", "start": {"date-parts": [[2010, 3, 5]], "date-time": "2010-03-05T00:00:00Z", "timestamp": 1267747200000}, "delay-in-days": 3350, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2001, 1, 1]]}, "DOI": "10.1017/cbo9780511663369.010", "type": "book-chapter", "created": {"date-parts": [[2010, 3, 5]], "date-time": "2010-03-05T14:16:29Z", "timestamp": 1267798589000}, "page": "126-140", "source": "Crossref", "is-referenced-by-count": 0, "title": ["MALT lymphoma and other marginal zone lymphomas"], "prefix": "10.1017", "author": [{"given": "Emanuele", "family": "Zucca", "sequence": "first", "affiliation": []}, {"given": "Francesco", "family": "Bertoni", "sequence": "additional", "affiliation": []}, {"given": "Andrew", "family": "Wotherspoon", "sequence": "additional", "affiliation": []}, {"given": "Andreas", "family": "Rosenwald", "sequence": "additional", "affiliation": []}, {"given": "German", "family": "Ott", "sequence": "additional", "affiliation": []}], "member": "56", "reference": [{"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib168", "author": "Zucca", "year": "2004", "volume-title": "MALT Lymphomas"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib166", "DOI": "10.3109/10428199709050889", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib164", "DOI": "10.1200/JCO.2005.08.128", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib160", "DOI": "10.1093/jnci/dji277", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib157", "doi-asserted-by": "crossref", "first-page": "1950", "DOI": "10.1182/blood.V95.6.1950", "article-title": "Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients", "volume": "95", "author": "Berger", "year": "2000", "journal-title": "Blood"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib175", "doi-asserted-by": "crossref", "first-page": "410", "DOI": "10.1182/blood.V96.2.410.014k22_410_419", "article-title": "The gastric marginal zone B-cell lymphoma of MALT type", "volume": "96", "author": "Zucca", "year": "2000", "journal-title": "Blood"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib172", "DOI": "10.3109/10428190109099348", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib158", "DOI": "10.1200/JCO.2005.05.018", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib156", "DOI": "10.1182/blood-2005-11-4659", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib161", "author": "Zucca", "year": "2004", "volume-title": "MALT Lymphomas"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib170", "DOI": "10.1016/S1470-2045(03)00981-1", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib169", "doi-asserted-by": "crossref", "first-page": "802", "DOI": "10.1182/blood.V95.3.802.003k19_802_806", "article-title": "Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed", "volume": "95", "author": "Thieblemont", "year": "2000", "journal-title": "Blood"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib171", "DOI": "10.1002/hon.743", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib163", "DOI": "10.1056/NEJMoa031887", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib159", "DOI": "10.1182/blood.V99.7.2541", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib165", "DOI": "10.1002/hon.762", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib176", "DOI": "10.1182/blood-2002-04-1279", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib162", "DOI": "10.1136/gut.52.11.1656", "doi-asserted-by": "publisher"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib174", "first-page": "11", "article-title": "Are antibiotics the treatment of choice for gastric lymphoma?", "volume": "3", "author": "Zucca", "year": "2004", "journal-title": "Curr. Hematol. Rep."}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib173", "author": "Zucca", "year": "2004", "volume-title": "MALT Lymphomas"}, {"key": "9780511663369.CBO9780511663369A019_CBO9780511663369bib167", "DOI": "10.1136/gut.52.6.912", "doi-asserted-by": "publisher"}], "container-title": ["Lymphoma: Pathology, Diagnosis and Treatment"], "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/219E171AE20E79FC39FED73F2D239C6A", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T22:35:43Z", "timestamp": 1575326143000}, "score": 39.414383, "issued": {"date-parts": [[2001, 1, 1]]}, "ISBN": ["9780521865449", "9780511663369"], "references-count": 21, "URL": "http://dx.doi.org/10.1017/cbo9780511663369.010", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T06:30:29Z", "timestamp": 1574490629471}, "reference-count": 28, "publisher": "Informa UK Limited", "issue": "5-6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2000, 1]]}, "DOI": "10.3109/10428190009059280", "type": "journal-article", "created": {"date-parts": [[2011, 1, 21]], "date-time": "2011-01-21T15:44:05Z", "timestamp": 1295624645000}, "page": "605-610", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Extranodal Marginal Zone B-Cell Lymphoma Genotyping byAlu\u2014 Polymerase Chain Reaction"], "prefix": "10.1080", "volume": "38", "author": [{"given": "Francesco", "family": "Bertoni", "sequence": "first", "affiliation": []}, {"given": "Roman", "family": "M\u00fcllenbach", "sequence": "additional", "affiliation": []}, {"given": "Massimo", "family": "Broggini", "sequence": "additional", "affiliation": []}, {"given": "Enrico", "family": "Roggero", "sequence": "additional", "affiliation": []}, {"given": "Franco", "family": "Cavalli", "sequence": "additional", "affiliation": []}, {"given": "Finbarr E.", "family": "Cotter", "sequence": "additional", "affiliation": []}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2009, 7]]}, "reference": [{"key": "CIT0001", "DOI": "10.1023/A:1008396618983", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1046/j.1365-2141.1998.00513.x", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.3109/10428199909145705", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1038/8767", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "author": "Dierlamm J.", "volume": "93", "first-page": "3601", "year": "1999", "journal-title": "Blood"}, {"key": "CIT0006", "DOI": "10.1016/S0092-8674(00)80957-5", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1073/pnas.85.13.4770", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "author": "Primrose S. B", "year": "1998", "volume-title": "Principles of genome analysis"}, {"key": "CIT0009", "DOI": "10.1073/pnas.86.17.6686", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1016/0888-7543(91)90413-9", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1016/0888-7543(90)90548-9", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.1002/(SICI)1098-2264(199701)18:1<30::AID-GCC4>3.0.CO;2-2", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "author": "Harris N. L.", "volume": "84", "first-page": "1361", "year": "1994", "journal-title": "Blood"}, {"key": "CIT0014", "DOI": "10.1056/NEJM199803193381205", "doi-asserted-by": "publisher"}, {"key": "CIT0015", "DOI": "10.1093/nar/27.1.12", "doi-asserted-by": "publisher"}, {"key": "CIT0016", "author": "Miillenbach R.", "volume": "4", "first-page": "249", "year": "1994", "journal-title": "DNA Sequence", "DOI": "10.3109/10425179409020848", "doi-asserted-by": "crossref"}, {"key": "CIT0017", "author": "Krajinovic M.", "volume": "56", "first-page": "2733", "year": "1996", "journal-title": "Cancer Research"}, {"key": "CIT0018", "DOI": "10.1086/302211", "doi-asserted-by": "publisher"}, {"key": "CIT0019", "DOI": "10.1002/(SICI)1098-2264(199905)25:1<6::AID-GCC2>3.0.CO;2-M", "doi-asserted-by": "publisher"}, {"key": "CIT0020", "author": "Slebos R. J.", "volume": "58", "first-page": "5333", "year": "1998", "journal-title": "Cancer Research"}, {"key": "CIT0021", "DOI": "10.1073/pnas.95.5.2390", "doi-asserted-by": "publisher"}, {"key": "CIT0022", "DOI": "10.1016/S0959-437X(99)80004-5", "doi-asserted-by": "publisher"}, {"key": "CIT0023", "DOI": "10.1073/pnas.95.17.10170", "doi-asserted-by": "publisher"}, {"key": "CIT0024", "DOI": "10.1073/pnas.89.21.10065", "doi-asserted-by": "publisher"}, {"key": "CIT0025", "author": "Arribas R.", "volume": "79", "first-page": "111", "year": "1999", "journal-title": "Laboratory Investigations"}, {"key": "CIT0026", "DOI": "10.1016/S0002-9440(10)65349-7", "doi-asserted-by": "publisher"}, {"key": "CIT0027", "author": "Carter D.", "volume": "33", "first-page": "343", "year": "1999", "journal-title": "Leukemia and Lymphoma", "DOI": "10.3109/10428199909058434", "doi-asserted-by": "crossref"}, {"key": "CIT0028", "DOI": "10.1038/4455", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.3109/10428190009059280", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 8]], "date-time": "2019-06-08T01:35:58Z", "timestamp": 1559957758000}, "score": 39.329796, "issued": {"date-parts": [[2000, 1]]}, "references-count": 28, "journal-issue": {"published-online": {"date-parts": [[2009, 7]]}, "published-print": {"date-parts": [[2000, 1]]}, "issue": "5-6"}, "alternative-id": ["10.3109/10428190009059280"], "URL": "http://dx.doi.org/10.3109/10428190009059280", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T10:07:57Z", "timestamp": 1574503677941}, "reference-count": 0, "publisher": "Ferrata Storti Foundation (Haematologica)", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Haematologica"], "published-print": {"date-parts": [[2013, 2, 1]]}, "DOI": "10.3324/haematol.2012.072587", "type": "journal-article", "created": {"date-parts": [[2012, 9, 15]], "date-time": "2012-09-15T11:22:15Z", "timestamp": 1347708135000}, "page": "264-268", "source": "Crossref", "is-referenced-by-count": 26, "title": ["Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie"], "prefix": "10.3324", "volume": "98", "author": [{"given": "M.", "family": "Troch", "sequence": "first", "affiliation": []}, {"given": "B.", "family": "Kiesewetter", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Willenbacher", "sequence": "additional", "affiliation": []}, {"given": "E.", "family": "Willenbacher", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Zebisch", "sequence": "additional", "affiliation": []}, {"given": "W.", "family": "Linkesch", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Fridrik", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Mullauer", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "Greil", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Raderer", "sequence": "additional", "affiliation": []}], "member": "1856", "published-online": {"date-parts": [[2012, 9, 14]]}, "container-title": ["Haematologica"], "language": "en", "deposited": {"date-parts": [[2014, 2, 25]], "date-time": "2014-02-25T15:23:11Z", "timestamp": 1393341791000}, "score": 39.278454, "issued": {"date-parts": [[2012, 9, 14]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 1, 31]]}, "published-print": {"date-parts": [[2013, 2, 1]]}, "issue": "2"}, "URL": "http://dx.doi.org/10.3324/haematol.2012.072587", "ISSN": ["0390-6078", "1592-8721"], "issn-type": [{"value": "0390-6078", "type": "print"}, {"value": "1592-8721", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:32:13Z", "timestamp": 1574303533172}, "reference-count": 26, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 3165, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Hematol. Oncol."], "published-print": {"date-parts": [[2007, 12]]}, "DOI": "10.1002/hon.825", "type": "journal-article", "created": {"date-parts": [[2007, 7, 2]], "date-time": "2007-07-02T14:24:28Z", "timestamp": 1183386268000}, "page": "184-188", "source": "Crossref", "is-referenced-by-count": 5, "title": ["Chromosome instability and translocation t(11;18) in primary gastric marginal zone B-cell lymphoma of MALT-type"], "prefix": "10.1002", "volume": "25", "author": [{"given": "Maria Grazia", "family": "Tibiletti", "sequence": "first", "affiliation": []}, {"given": "Katia", "family": "Milani", "sequence": "additional", "affiliation": []}, {"given": "Vittoria", "family": "Martin", "sequence": "additional", "affiliation": []}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": []}, {"given": "Teresio", "family": "Motta", "sequence": "additional", "affiliation": []}, {"given": "Sergio", "family": "Cortelazzo", "sequence": "additional", "affiliation": []}, {"given": "Graziella", "family": "Pinotti", "sequence": "additional", "affiliation": []}, {"given": "Luca", "family": "Mazzucchelli", "sequence": "additional", "affiliation": []}, {"given": "Giancarlo", "family": "Pruneri", "sequence": "additional", "affiliation": []}, {"given": "Giovanni", "family": "Martinelli", "sequence": "additional", "affiliation": []}, {"given": "Renzo", "family": "Barbazza", "sequence": "additional", "affiliation": []}, {"given": "Carlo", "family": "Capella", "sequence": "additional", "affiliation": []}, {"given": "Francesco", "family": "Bertoni", "sequence": "additional", "affiliation": []}, {"name": "On behalf of the International Extranodal Lymphoma Study Group (IELSG)", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007]]}, "reference": [{"key": "10.1002/hon.825-BIB1", "author": "Isaacson", "volume": "4", "first-page": "644", "year": "2004", "journal-title": "Nat Rev Cancer", "DOI": "10.1038/nrc1409", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB2", "author": "Zucca", "first-page": "381", "year": "2006", "unstructured": ", . Marginal zone B-cell lymphomas. In The Lymphomas (2nd edn), , (eds). Saunders Elsevier: Philadelphia, PA, USA, 2006; 381\u2013396.", "volume-title": "The Lymphomas", "DOI": "10.1016/B978-0-7216-0081-9.50025-X", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB3", "author": "Bertoni", "volume": "23", "first-page": "6415", "year": "2005", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2005.05.018", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB4", "author": "Dierlamm", "volume": "93", "first-page": "3601", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/hon.825-BIB5", "author": "Willis", "volume": "96", "first-page": "35", "year": "1999", "journal-title": "Cell", "DOI": "10.1016/S0092-8674(00)80957-5", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB6", "author": "Streubel", "volume": "101", "first-page": "2335", "year": "2002", "journal-title": "Blood", "DOI": "10.1182/blood-2002-09-2963", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB7", "author": "Streubel", "volume": "19", "first-page": "652", "year": "2005", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2403644", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB8", "author": "Bertoni", "volume": "116", "first-page": "22", "year": "2006", "journal-title": "J Clin Invest", "DOI": "10.1172/JCI27476", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB9", "author": "Farinha", "volume": "23", "first-page": "6370", "year": "2005", "journal-title": "J Clin Oncol", "DOI": "10.1200/JCO.2005.05.011", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB10", "author": "Murga Penas", "volume": "17", "first-page": "2225", "year": "2003", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2403122", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB11", "author": "Ye", "volume": "102", "first-page": "1012", "year": "2003", "journal-title": "Blood", "DOI": "10.1182/blood-2002-11-3502", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB12", "author": "Dierlamm", "volume": "87", "first-page": "299", "year": "1996", "journal-title": "Blood"}, {"key": "10.1002/hon.825-BIB13", "author": "Dierlamm", "volume": "11", "first-page": "747", "year": "1997", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2400635", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB14", "author": "Auer", "volume": "8", "first-page": "979", "year": "1997", "journal-title": "Ann Oncol", "DOI": "10.1023/A:1008202303666", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB15", "author": "Bertoni", "volume": "99", "first-page": "2541", "year": "2002", "journal-title": "Blood", "DOI": "10.1182/blood.V99.7.2541", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB16", "author": "Hancock", "volume": "16", "first-page": "v57", "year": "2005", "journal-title": "Ann Oncol"}, {"key": "10.1002/hon.825-BIB17", "author": "Isaacson", "first-page": "157", "year": "2001", "unstructured": ", , et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, , , (eds). IARC Press: Lyon, 2001; 157\u2013160.", "volume-title": "World Health Organization Classification of Tumours Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues"}, {"key": "10.1002/hon.825-BIB18", "author": "Wotherspoon", "volume": "342", "first-page": "575", "year": "1993", "journal-title": "Lancet", "DOI": "10.1016/0140-6736(93)91409-F", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB19", "author": "Tibiletti", "volume": "155", "first-page": "143", "year": "2004", "journal-title": "Cancer Genet Cytogenet", "DOI": "10.1016/j.cancergencyto.2004.03.005", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB20", "author": "Shaffer", "year": "2005", "unstructured": "(eds). ISCN (2005): An International System for Human Cytogenetic Nomenclature. S. Karger: Basel, 2005.", "volume-title": "ISCN (2005): An International System for Human Cytogenetic Nomenclature"}, {"key": "10.1002/hon.825-BIB21", "author": "Lengauer", "volume": "396", "first-page": "643", "year": "1998", "journal-title": "Nature", "DOI": "10.1038/25292", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB22", "author": "Remstein", "volume": "18", "first-page": "156", "year": "2004", "journal-title": "Leukemia", "DOI": "10.1038/sj.leu.2403185", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB23", "author": "Bernasconi", "year": "2007", "journal-title": "Hum Pathol"}, {"key": "10.1002/hon.825-BIB24", "author": "Chen", "volume": "159", "first-page": "387", "year": "2001", "journal-title": "Am J Pathol", "DOI": "10.1016/S0002-9440(10)61708-7", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB25", "author": "Hosokawa", "volume": "10", "first-page": "25", "year": "2005", "journal-title": "Apoptosis", "DOI": "10.1007/s10495-005-6059-6", "doi-asserted-by": "crossref"}, {"key": "10.1002/hon.825-BIB26", "author": "Liu", "volume": "357", "first-page": "39", "year": "2001", "journal-title": "Lancet", "DOI": "10.1016/S0140-6736(00)03571-6", "doi-asserted-by": "crossref"}], "container-title": ["Hematological Oncology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhon.825", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/hon.825", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 1]], "date-time": "2019-02-01T05:23:45Z", "timestamp": 1548998625000}, "score": 39.249176, "issued": {"date-parts": [[2007]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2007, 12]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1002/hon.825", "relation": {"cites": []}, "ISSN": ["0278-0232", "1099-1069"], "issn-type": [{"value": "0278-0232", "type": "print"}, {"value": "1099-1069", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T12:01:06Z", "timestamp": 1574424066011}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2010, 4, 1]], "date-time": "2010-04-01T00:00:00Z", "timestamp": 1270080000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer Supplements"], "published-print": {"date-parts": [[2010, 4]]}, "DOI": "10.1016/s1359-6349(10)70675-3", "type": "journal-article", "created": {"date-parts": [[2010, 4, 19]], "date-time": "2010-04-19T09:05:31Z", "timestamp": 1271667931000}, "page": "3-4", "source": "Crossref", "is-referenced-by-count": 0, "title": ["4 Marginal zone B-cell lymphomas"], "prefix": "10.1016", "volume": "8", "author": [{"given": "E.", "family": "Zucca", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer Supplements"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1359634910706753?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1359634910706753?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 11]], "date-time": "2018-12-11T19:21:38Z", "timestamp": 1544556098000}, "score": 38.481583, "issued": {"date-parts": [[2010, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 4]]}, "issue": "4"}, "alternative-id": ["S1359634910706753"], "URL": "http://dx.doi.org/10.1016/s1359-6349(10)70675-3", "ISSN": ["1359-6349"], "issn-type": [{"value": "1359-6349", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T07:23:10Z", "timestamp": 1574580190950}, "publisher-location": "Cham", "reference-count": 115, "publisher": "Springer International Publishing", "isbn-type": [{"value": "9783319131498", "type": "print"}, {"value": "9783319131504", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2015]]}, "DOI": "10.1007/978-3-319-13150-4_9", "type": "book-chapter", "created": {"date-parts": [[2015, 2, 6]], "date-time": "2015-02-06T02:05:53Z", "timestamp": 1423188353000}, "page": "227-249", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Management of the Marginal Zone Lymphomas"], "prefix": "10.1007", "author": [{"given": "Barbara", "family": "Vannata", "sequence": "first", "affiliation": []}, {"given": "Anastasios", "family": "Stathis", "sequence": "additional", "affiliation": []}, {"given": "Emanuele", "family": "Zucca", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2015, 2, 7]]}, "reference": [{"key": "9_CR1", "year": "2008", "unstructured": "Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon", "volume-title": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues"}, {"issue": "12", "key": "9_CR2", "first-page": "1134", "volume": "25", "author": "F Bertoni", "year": "2011", "unstructured": "Bertoni F, Coiffier B, Salles G, Stathis A, Traverse-Glehen A, Thieblemont C et al (2011) MALT lymphomas: pathogenesis can drive treatment. Oncology 25(12):1134\u20131142 47", "journal-title": "Oncology"}, {"issue": "3", "key": "9_CR3", "doi-asserted-by": "publisher", "first-page": "581", "DOI": "10.1182/blood-2009-06-228015", "volume": "115", "author": "VJ Craig", "year": "2010", "unstructured": "Craig VJ, Arnold I, Gerke C, Huynh MQ, Wundisch T, Neubauer A et al (2010) Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood 115(3):581\u2013591. doi:\n                  10.1182/blood-2009-06-228015", "journal-title": "Blood"}, {"issue": "2", "key": "9_CR4", "doi-asserted-by": "crossref", "first-page": "263", "DOI": "10.1016/S0046-8177(00)80233-6", "volume": "31", "author": "E Roggero", "year": "2000", "unstructured": "Roggero E, Zucca E, Mainetti C, Bertoni F, Valsangiacomo C, Pedrinis E et al (2000) Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 31(2):263\u2013268", "journal-title": "Hum Pathol"}, {"issue": "8", "key": "9_CR5", "doi-asserted-by": "crossref", "first-page": "586", "DOI": "10.1093/jnci/djh102", "volume": "96", "author": "AJ Ferreri", "year": "2004", "unstructured": "Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell\u2019Oro S, Fleischhauer K et al (2004) Evidence for an association between chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 96(8):586\u2013594", "journal-title": "J Natl Cancer Inst"}, {"issue": "24", "key": "9_CR6", "doi-asserted-by": "publisher", "first-page": "2988", "DOI": "10.1200/jco.2011.41.4466", "volume": "30", "author": "AJ Ferreri", "year": "2012", "unstructured": "Ferreri AJ, Govi S, Pasini E, Mappa S, Bertoni F, Zaja F et al (2012) Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol 30(24):2988\u20132994. doi:\n                  10.1200/jco.2011.41.4466", "journal-title": "J Clin Oncol"}, {"issue": "5", "key": "9_CR7", "doi-asserted-by": "publisher", "first-page": "835", "DOI": "10.1093/annonc/mdm513", "volume": "19", "author": "AJM Ferreri", "year": "2008", "unstructured": "Ferreri AJM, Dolcetti R, Du MQ, Doglioni C, Giordano Resti A, Politi LS et al (2008) Ocular adnexal MALT lymphoma: an intriguing model for antigen-driven lymphomagenesis and microbial-targeted therapy. Ann Oncol 19(5):835\u2013846. doi:\n                  10.1093/annonc/mdm513", "journal-title": "Ann Oncol"}, {"issue": "3", "key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1056/NEJMoa031887", "volume": "350", "author": "M Lecuit", "year": "2004", "unstructured": "Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F et al (2004) Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 350(3):239\u2013248", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "9_CR9", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1056/NEJMoa013376", "volume": "347", "author": "O Hermine", "year": "2002", "unstructured": "Hermine O, Lefrere F, Bronowicki JP, Mariette X, Jondeau K, Eclache-Saudreau V et al (2002) Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347(2):89\u201394", "journal-title": "N Engl J Med"}, {"issue": "1", "key": "9_CR10", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1002/cncr.11893", "volume": "100", "author": "L Arcaini", "year": "2004", "unstructured": "Arcaini L, Paulli M, Boveri E, Vallisa D, Bernuzzi P, Orlandi E et al (2004) Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 100(1):107\u2013115", "journal-title": "Cancer"}, {"issue": "2", "key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "346", "DOI": "10.1093/annonc/mdl388", "volume": "18", "author": "L Arcaini", "year": "2007", "unstructured": "Arcaini L, Burcheri S, Rossi A, Paulli M, Bruno R, Passamonti F et al (2007) Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT. Ann Oncol 18(2):346\u2013350. doi:\n                  10.1093/annonc/mdl388", "journal-title": "Ann Oncol"}, {"issue": "6", "key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "1189", "DOI": "10.1093/annonc/mdp454", "volume": "21", "author": "M Paulli", "year": "2010", "unstructured": "Paulli M, Arcaini L, Lucioni M, Boveri E, Capello D, Passamonti F et al (2010) Subcutaneous \u2018lipoma-like\u2019 B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. Ann Oncol 21(6):1189\u20131195. doi:\n                  10.1093/annonc/mdp454", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "9_CR13", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1111/j.1365-2141.2004.04993.x", "volume": "126", "author": "A Ambrosetti", "year": "2004", "unstructured": "Ambrosetti A, Zanotti R, Pattaro C, Lenzi L, Chilosi M, Caramaschi P et al (2004) Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 126(1):43\u201349", "journal-title": "Br J Haematol"}, {"issue": "8", "key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "644", "DOI": "10.1038/nrc1409", "volume": "4", "author": "PG Isaacson", "year": "2004", "unstructured": "Isaacson PG, Du MQ (2004) MALT lymphoma: from morphology to molecules. Nat Rev Cancer 4(8):644\u2013653", "journal-title": "Nat Rev Cancer"}, {"issue": "7", "key": "9_CR15", "first-page": "2700", "volume": "109", "author": "PJ Jost", "year": "2007", "unstructured": "Jost PJ, Ruland J (2007) Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences and therapeutic implications. Blood 109(7):2700\u20132707", "journal-title": "Blood"}, {"issue": "1", "key": "9_CR16", "doi-asserted-by": "crossref", "first-page": "22", "DOI": "10.1172/JCI27476", "volume": "116", "author": "F Bertoni", "year": "2006", "unstructured": "Bertoni F, Zucca E (2006) Delving deeper into MALT lymphoma biology. J Clin Investig 116(1):22\u201326", "journal-title": "J Clin Investig"}, {"key": "9_CR17", "author": "FD Langel", "year": "2008", "unstructured": "Langel FD, Jain NA, Rossman JS, Kingeter LM, Kashyap AK, Schaefer BC (2008) Multiple protein domains mediate interaction between Bcl10 and MALT1. J Biol Chem. doi:\n                  10.1074/jbc.M800670200", "journal-title": "J Biol Chem", "DOI": "10.1074/jbc.M800670200", "doi-asserted-by": "publisher"}, {"issue": "Pt 1", "key": "9_CR18", "doi-asserted-by": "crossref", "first-page": "31", "DOI": "10.1242/jcs.00904", "volume": "117", "author": "PC Lucas", "year": "2004", "unstructured": "Lucas PC, McAllister-Lucas LM, Nunez G (2004) NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci 117(Pt 1):31\u201339", "journal-title": "J Cell Sci"}, {"issue": "10", "key": "9_CR19", "doi-asserted-by": "crossref", "first-page": "5270", "DOI": "10.1158/0008-5472.CAN-05-4590", "volume": "66", "author": "M Baens", "year": "2006", "unstructured": "Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al (2006) Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 66(10):5270\u20135277", "journal-title": "Cancer Res"}, {"key": "9_CR20", "unstructured": "Novak U, Rinaldi A, Kwee I, Murty VV, Nandula SV, Rancoita PMV et al. (2008) The NF-kB pathway component A20 (TNFAIP3) is commonly inactivated by DNA mutations and deletions in extranodal marginal zone B-cell lymphoma (EMZL). Ann Oncol abstract at the 10-ICML"}, {"issue": "7", "key": "9_CR21", "doi-asserted-by": "publisher", "first-page": "1064", "DOI": "10.3324/haematol.2011.040402", "volume": "96", "author": "I Kwee", "year": "2011", "unstructured": "Kwee I, Rancoita PM, Rinaldi A, Ferreri AJ, Bhagat G, Gascoyne RD et al (2011) Genomic profiles of MALT lymphomas: variability across anatomical sites. Haematologica 96(7):1064\u20131066. doi:\n                  10.3324/haematol.2011.040402", "journal-title": "Haematologica"}, {"key": "9_CR22", "unstructured": "Zucca E, Copie-Bergman C, Ricardi U, Thieblemont C, Raderer M, Ladetto M (2013) Gastric marginal zone lymphoma of MALT type: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 24(6):vi144\u2013vi148. doi:\n                  10.1093/annonc/mdt343", "DOI": "10.1093/annonc/mdt343", "doi-asserted-by": "publisher"}, {"key": "9_CR23", "author": "PG Isaacson", "first-page": "214", "year": "2008", "unstructured": "Isaacson PG, Chott A, Nakamura S, Muller-Hermelink HK, Harris NL, Swerdlow S (2008) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 214\u2013217", "volume-title": "WHO classification of tumours of haematopoietic and lymphoid tissues"}, {"issue": "4", "key": "9_CR24", "doi-asserted-by": "publisher", "first-page": "857", "DOI": "10.1093/annonc/mds643", "volume": "24", "author": "M Dreyling", "year": "2013", "unstructured": "Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O et al (2013) ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 24(4):857\u2013877. doi:\n                  10.1093/annonc/mds643", "journal-title": "Ann Oncol"}, {"issue": "7", "key": "9_CR25", "doi-asserted-by": "crossref", "first-page": "2464", "DOI": "10.1182/blood-2002-07-2216", "volume": "101", "author": "V Franco", "year": "2003", "unstructured": "Franco V, Florena AM, Iannitto E (2003) Splenic marginal zone lymphoma. Blood 101(7):2464\u20132472", "journal-title": "Blood"}, {"issue": "3", "key": "9_CR26", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1038/sj.leu.2405068", "volume": "22", "author": "E Matutes", "year": "2008", "unstructured": "Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A et al (2008) Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 22(3):487\u2013495", "journal-title": "Leukemia"}, {"issue": "7", "key": "9_CR27", "doi-asserted-by": "crossref", "first-page": "2489", "DOI": "10.1182/blood-2002-04-1279", "volume": "101", "author": "E Zucca", "year": "2003", "unstructured": "Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101(7):2489\u20132495", "journal-title": "Blood"}, {"issue": "2", "key": "9_CR28", "doi-asserted-by": "publisher", "first-page": "201", "DOI": "10.3324/haematol.11835", "volume": "93", "author": "JP Boer de", "year": "2008", "unstructured": "de Boer JP, Hiddink RF, Raderer M, Antonini N, Aleman BMP, Boot H et al (2008) Dissemination patterns in non-gastric MALT lymphoma. Haematologica 93(2):201\u2013206. doi:\n                  10.3324/haematol.11835", "journal-title": "Haematologica"}, {"key": "9_CR29", "author": "C Thieblemont", "first-page": "60", "year": "2004", "unstructured": "Thieblemont C, Coiffier B (2004) MALT lymphoma: sites of presentations, clinical features and staging procedures. In: Zucca E, Bertoni F (eds) MALT lymphomas. Landes Bioscience/Kluwer Academic, Georgetown, pp 60\u201380", "volume-title": "MALT lymphomas"}, {"issue": "19", "key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "3136", "DOI": "10.1200/JCO.2006.06.0723", "volume": "24", "author": "M Raderer", "year": "2006", "unstructured": "Raderer M, Wohrer S, Streubel B, Troch M, Turetschek K, Jager U et al (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24(19):3136\u20133141", "journal-title": "J Clin Oncol"}, {"issue": "1", "key": "9_CR31", "first-page": "86", "volume": "28", "author": "E Zucca", "year": "2014", "unstructured": "Zucca E, Stathis A, Bertoni F (2014) The management of nongastric MALT lymphomas. Oncology 28(1):86\u201393", "journal-title": "Oncology"}, {"issue": "2", "key": "9_CR32", "first-page": "194", "volume": "26", "author": "C Thieblemont", "year": "2012", "unstructured": "Thieblemont C, Davi F, Noguera ME, Briere J, Bertoni F, Zucca E et al (2012) Splenic marginal zone lymphoma: current knowledge and future directions. Oncology 26(2):194\u2013202", "journal-title": "Oncology"}, {"key": "9_CR33", "doi-asserted-by": "publisher", "first-page": "638185", "DOI": "10.1155/2012/638185", "volume": "2012", "author": "L Arcaini", "year": "2012", "unstructured": "Arcaini L, Merli M, Volpetti S, Rattotti S, Gotti M, Zaja F (2012) Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy. Clin dev immunol 2012:638185. doi:\n                  10.1155/2012/638185", "journal-title": "Clin dev immunol"}, {"issue": "12", "key": "9_CR34", "doi-asserted-by": "publisher", "first-page": "4643", "DOI": "10.1182/blood-2005-11-4659", "volume": "107", "author": "L Arcaini", "year": "2006", "unstructured": "Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M et al (2006) Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 107(12):4643\u20134649. doi:\n                  10.1182/blood-2005-11-4659", "journal-title": "Blood"}, {"issue": "2", "key": "9_CR35", "doi-asserted-by": "publisher", "first-page": "164", "DOI": "10.1111/bjh.12011", "volume": "159", "author": "C Montalban", "year": "2012", "unstructured": "Montalban C, Abraira V, Arcaini L, Domingo-Domenech E, Guisado-Vasco P, Iannitto E et al (2012) Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases. Br J Haematol 159(2):164\u2013171. doi:\n                  10.1111/bjh.12011", "journal-title": "Br J Haematol"}, {"issue": "6", "key": "9_CR36", "doi-asserted-by": "publisher", "first-page": "1240", "DOI": "10.3109/10428194.2013.840888", "volume": "55", "author": "MK Angelopoulou", "year": "2014", "unstructured": "Angelopoulou MK, Kalpadakis C, Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP (2014) Nodal marginal zone lymphoma. Leuk Lymphoma 55(6):1240\u20131250. doi:\n                  10.3109/10428194.2013.840888", "journal-title": "Leuk Lymphoma"}, {"issue": "7", "key": "9_CR37", "doi-asserted-by": "publisher", "first-page": "1003", "DOI": "10.3324/haematol.2012.083386", "volume": "98", "author": "M Brand van den", "year": "2013", "unstructured": "van den Brand M, van Krieken JH (2013) Recognizing nodal marginal zone lymphoma: recent advances and pitfalls. A systematic review. Haematologica 98(7):1003\u20131013. doi:\n                  10.3324/haematol.2012.083386", "journal-title": "Haematologica"}, {"issue": "1", "key": "9_CR38", "first-page": "92", "volume": "26", "author": "A Traverse-Glehen", "year": "2012", "unstructured": "Traverse-Glehen A, Bertoni F, Thieblemont C, Zucca E, Coiffier B, Berger F et al (2012) Nodal marginal zone B-cell lymphoma: a diagnostic and therapeutic dilemma. Oncology 26(1):92\u201399 103-4", "journal-title": "Oncology"}, {"issue": "1", "key": "9_CR39", "doi-asserted-by": "publisher", "first-page": "44", "DOI": "10.1111/j.1349-7006.2006.00345.x", "volume": "98", "author": "M Kojima", "year": "2007", "unstructured": "Kojima M, Inagaki H, Motoori T, Itoh H, Shimizu K, Tamaki Y et al (2007) Clinical implications of nodal marginal zone B-cell lymphoma among Japanese: study of 65 cases. Cancer Sci 98(1):44\u201349. doi:\n                  10.1111/j.1349-7006.2006.00345.x", "journal-title": "Cancer Sci"}, {"issue": "6", "key": "9_CR40", "doi-asserted-by": "crossref", "first-page": "762", "DOI": "10.1097/00000478-200306000-00006", "volume": "27", "author": "FI Camacho", "year": "2003", "unstructured": "Camacho FI, Algara P, Mollejo M, Garcia JF, Montalban C, Martinez N et al (2003) Nodal marginal zone lymphoma: a heterogeneous tumor: a comprehensive analysis of a series of 27 cases. Am J Surg Pathol 27(6):762\u2013771", "journal-title": "Am J Surg Pathol"}, {"issue": "1", "key": "9_CR41", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1038/leu.2012.257", "volume": "27", "author": "N Gachard", "year": "2013", "unstructured": "Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D et al (2013) IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenstrom macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia 27(1):183\u2013189. doi:\n                  10.1038/leu.2012.257", "journal-title": "Leukemia"}, {"issue": "11", "key": "9_CR42", "doi-asserted-by": "publisher", "first-page": "781", "DOI": "10.1007/s00277-006-0160-y", "volume": "85", "author": "SY Oh", "year": "2006", "unstructured": "Oh SY, Ryoo BY, Kim WS, Kim K, Lee J, Kim HJ et al (2006) Nodal marginal zone B-cell lymphoma: analysis of 36 cases. Clinical presentation and treatment outcomes of nodal marginal zone B-cell lymphoma. Ann Hematol 85(11):781\u2013786. doi:\n                  10.1007/s00277-006-0160-y", "journal-title": "Ann Hematol"}, {"issue": "6", "key": "9_CR43", "first-page": "1950", "volume": "95", "author": "F Berger", "year": "2000", "unstructured": "Berger F, Felman P, Thieblemont C, Pradier T, Baseggio L, Bryon PA et al (2000) Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients. Blood 95(6):1950\u20131956", "journal-title": "Blood"}, {"issue": "8", "key": "9_CR44", "doi-asserted-by": "crossref", "first-page": "2486", "DOI": "10.1200/JCO.1999.17.8.2486", "volume": "17", "author": "BN Nathwani", "year": "1999", "unstructured": "Nathwani BN, Anderson JR, Armitage JO, Cavalli F, Diebold J, Drachenberg MR et al (1999) Marginal zone B-cell lymphoma: a clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin\u2019s lymphoma classification project. J Clin Oncol 17(8):2486\u20132492", "journal-title": "J Clin Oncol"}, {"key": "9_CR45", "unstructured": "Treglia G, Zucca E, Sadeghi R, Cavalli F, Giovanella L, Ceriani L (2014) Detection rate of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with marginal zone lymphoma of MALT type: a meta-analysis. Hematological oncology doi: \n                  10.1002/hon.2152\n                  \n                . [Epub ahead of print, July 22, 2014]", "DOI": "10.1002/hon.2152", "doi-asserted-by": "publisher"}, {"issue": "31", "key": "9_CR46", "doi-asserted-by": "crossref", "first-page": "8018", "DOI": "10.1200/JCO.2005.02.3903", "volume": "23", "author": "T Wundisch", "year": "2005", "unstructured": "Wundisch T, Thiede C, Morgner A, Dempfle A, Gunther A, Liu H et al (2005) Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J Clin Oncol 23(31):8018\u20138024", "journal-title": "J Clin Oncol"}, {"issue": "9", "key": "9_CR47", "doi-asserted-by": "crossref", "first-page": "1539", "DOI": "10.1093/annonc/mdi277", "volume": "16", "author": "C Montalban", "year": "2005", "unstructured": "Montalban C, Santon A, Redondo C, Garcia-Cosio M, Boixeda D, Vazquez-Sequeiros E et al (2005) Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 16(9):1539\u20131544", "journal-title": "Ann Oncol"}, {"issue": "9", "key": "9_CR48", "doi-asserted-by": "crossref", "first-page": "1324", "DOI": "10.1038/sj.bjc.6603708", "volume": "96", "author": "JS Kim", "year": "2007", "unstructured": "Kim JS, Chung SJ, Choi YS, Cheon JH, Kim CW, Kim SG et al (2007) Helicobacter pylori eradication for low-grade gastric mucosa-associated lymphoid tissue lymphoma is more successful in inducing remission in distal compared to proximal disease. Br J Cancer 96(9):1324\u20131328", "journal-title": "Br J Cancer"}, {"issue": "6", "key": "9_CR49", "doi-asserted-by": "publisher", "first-page": "1086", "DOI": "10.1093/annonc/mdn760", "volume": "20", "author": "A Stathis", "year": "2009", "unstructured": "Stathis A, Chini C, Bertoni F, Proserpio I, Capella C, Mazzucchelli L et al (2009) Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol 20(6):1086\u20131093. doi:\n                  10.1093/annonc/mdn760", "journal-title": "Ann Oncol"}, {"issue": "1", "key": "9_CR50", "doi-asserted-by": "crossref", "first-page": "79", "DOI": "10.1620/tjem.214.79", "volume": "214", "author": "S Terai", "year": "2008", "unstructured": "Terai S, Iijima K, Kato K, Dairaku N, Suzuki T, Yoshida M et al (2008) Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med 214(1):79\u201387", "journal-title": "Tohoku J Exp Med"}, {"issue": "7", "key": "9_CR51", "doi-asserted-by": "publisher", "first-page": "467", "DOI": "10.1016/j.dld.2008.09.009", "volume": "41", "author": "A Andriani", "year": "2009", "unstructured": "Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M et al (2009) Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study. Dig Liver Dis 41(7):467\u2013473. doi:\n                  10.1016/j.dld.2008.09.009\n                  \n                 (official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver)", "journal-title": "Dig Liver Dis"}, {"key": "9_CR52", "unstructured": "Ruskone-Fourmestraux A, Fischbach W, Aleman BM, Boot H, Du MQ, Megraud F et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60(6):747\u201358. doi:\n                  10.1136/gut.2010.224949", "DOI": "10.1136/gut.2010.224949", "doi-asserted-by": "publisher"}, {"issue": "1", "key": "9_CR53", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1111/bjh.12078", "volume": "160", "author": "C Copie-Bergman", "year": "2013", "unstructured": "Copie-Bergman C, Wotherspoon AC, Capella C, Motta T, Pedrinis E, Pileri SA et al (2013) Gela histological scoring system for post-treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice. Br J Haematol 160(1):47\u201352. doi:\n                  10.1111/bjh.12078", "journal-title": "Br J Haematol"}, {"issue": "4", "key": "9_CR54", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1136/gutjnl-2011-300495", "volume": "61", "author": "S Nakamura", "year": "2012", "unstructured": "Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M et al (2012) Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan. Gut 61(4):507\u2013513. doi:\n                  10.1136/gutjnl-2011-300495", "journal-title": "Gut"}, {"issue": "12", "key": "9_CR55", "doi-asserted-by": "crossref", "first-page": "1685", "DOI": "10.1136/gut.2006.096420", "volume": "56", "author": "W Fischbach", "year": "2007", "unstructured": "Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wundisch T, Neubauer A, Raderer M et al (2007) Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Gut 56(12):1685\u20131687", "journal-title": "Gut"}, {"issue": "16", "key": "9_CR56", "doi-asserted-by": "publisher", "first-page": "2470", "DOI": "10.1016/j.ejca.2008.07.005", "volume": "44", "author": "LG Capelle", "year": "2008", "unstructured": "Capelle LG, de Vries AC, Looman CW, Casparie MK, Boot H, Meijer GA et al (2008) Gastric MALT lymphoma: Epidemiology and high adenocarcinoma risk in a nation-wide study. Eur J Cancer 44(16):2470\u20132476. doi:\n                  10.1016/j.ejca.2008.07.005", "journal-title": "Eur J Cancer"}, {"issue": "4", "key": "9_CR57", "doi-asserted-by": "publisher", "first-page": "936", "DOI": "10.1053/j.gastro.2012.06.035", "volume": "143", "author": "T Wundisch", "year": "2012", "unstructured": "Wundisch T, Dieckhoff P, Greene B, Thiede C, Wilhelm C, Stolte M et al (2012) Second cancers and residual disease in patients treated for gastric mucosa-associated lymphoid tissue lymphoma by Helicobacter pylori eradication and followed for 10 years. Gastroenterology 143(4):936\u2013942. doi:\n                  10.1053/j.gastro.2012.06.035\n                  \n                 (quiz e13\u2013e14)", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "9_CR58", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1053/gast.1997.v113.pm9322502", "volume": "113", "author": "M Sackmann", "year": "1997", "unstructured": "Sackmann M, Morgner A, Rudolph B, Neubauer A, Thiede C, Schulz H et al (1997) Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging MALT Lymphoma study group. Gastroenterology 113(4):1087\u20131090", "journal-title": "Gastroenterology"}, {"issue": "4", "key": "9_CR59", "doi-asserted-by": "crossref", "first-page": "454", "DOI": "10.1136/gut.48.4.454", "volume": "48", "author": "S Nakamura", "year": "2001", "unstructured": "Nakamura S, Matsumoto T, Suekane H, Takeshita M, Hizawa K, Kawasaki M et al (2001) Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut 48(4):454\u2013460", "journal-title": "Gut"}, {"issue": "3", "key": "9_CR60", "doi-asserted-by": "crossref", "first-page": "297", "DOI": "10.1136/gut.48.3.297", "volume": "48", "author": "A Ruskone-Fourmestraux", "year": "2001", "unstructured": "Ruskone-Fourmestraux A, Lavergne A, Aegerter PH, Megraud F, Palazzo L, de Mascarel A et al (2001) Predictive factors for regression of gastric MALT lymphoma after anti- Helicobacter pylori treatment. Gut 48(3):297\u2013303", "journal-title": "Gut"}, {"issue": "2", "key": "9_CR61", "doi-asserted-by": "crossref", "first-page": "88", "DOI": "10.7326/0003-4819-131-2-199907200-00003", "volume": "131", "author": "G Steinbach", "year": "1999", "unstructured": "Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM et al (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 131(2):88\u201395", "journal-title": "Ann Intern Med"}, {"issue": "5", "key": "9_CR62", "doi-asserted-by": "crossref", "first-page": "1286", "DOI": "10.1053/gast.2002.33047", "volume": "122", "author": "H Liu", "year": "2002", "unstructured": "Liu H, Ye H, Ruskone-Fourmestraux A, De Jong D, Pileri S, Thiede C et al (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology 122(5):1286\u20131294", "journal-title": "Gastroenterology"}, {"issue": "18", "key": "9_CR63", "doi-asserted-by": "crossref", "first-page": "1350", "DOI": "10.1093/jnci/89.18.1350", "volume": "89", "author": "A Neubauer", "year": "1997", "unstructured": "Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B et al (1997) Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 89(18):1350\u20131355", "journal-title": "J Natl Cancer Inst"}, {"issue": "12", "key": "9_CR64", "first-page": "4014", "volume": "95", "author": "B Alpen", "year": "2000", "unstructured": "Alpen B, Neubauer A, Dierlamm J, Marynen P, Thiede C, Bayerdorfer E et al (2000) Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 95(12):4014\u20134015", "journal-title": "Blood"}, {"issue": "6", "key": "9_CR65", "doi-asserted-by": "publisher", "first-page": "1387", "DOI": "10.1007/s00280-011-1631-y", "volume": "68", "author": "SH Kuo", "year": "2011", "unstructured": "Kuo SH, Cheng AL, Lin CW, Hsu CH, Wu MS, Yeh KH et al (2011) t(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement. Cancer Chemother Pharmacol 68(6):1387\u20131395. doi:\n                  10.1007/s00280-011-1631-y", "journal-title": "Cancer Chemother Pharmacol"}, {"issue": "22", "key": "9_CR66", "doi-asserted-by": "crossref", "first-page": "5061", "DOI": "10.1200/JCO.2005.05.660", "volume": "23", "author": "M Levy", "year": "2005", "unstructured": "Levy M, Copie-Bergman C, Gameiro C, Chaumette MT, Delfau-Larue MH, Haioun C et al (2005) Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 23(22):5061\u20135066", "journal-title": "J Clin Oncol"}, {"issue": "2", "key": "9_CR67", "doi-asserted-by": "publisher", "first-page": "284", "DOI": "10.3109/10428190903431820", "volume": "51", "author": "M Levy", "year": "2010", "unstructured": "Levy M, Copie-Bergman C, Molinier-Frenkel V, Riou A, Haioun C, Gaulard P et al (2010) Treatment of t(11;18)-positive gastric mucosa-associated lymphoid tissue lymphoma with rituximab and chlorambucil: clinical, histological, and molecular follow-up. Leuk Lymphoma 51(2):284\u2013290. doi:\n                  10.3109/10428190903431820", "journal-title": "Leuk Lymphoma"}, {"issue": "2", "key": "9_CR68", "doi-asserted-by": "crossref", "first-page": "257", "DOI": "10.1080/1042819021000035680", "volume": "44", "author": "C Thieblemont", "year": "2003", "unstructured": "Thieblemont C, Dumontet C, Bouafia F, Hequet O, Arnaud P, Espinouse D et al (2003) Outcome in relation to treatment modalities in 48 patients with localized gastric MALT lymphoma: a retrospective study of patients treated during 1976-2001. Leuk Lymphoma 44(2):257\u2013262", "journal-title": "Leuk Lymphoma"}, {"issue": "5\u20136", "key": "9_CR69", "doi-asserted-by": "crossref", "first-page": "527", "DOI": "10.3109/10428199709050889", "volume": "26", "author": "G Pinotti", "year": "1997", "unstructured": "Pinotti G, Zucca E, Roggero E, Pascarella A, Bertoni F, Savio A et al (1997) Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 26(5\u20136):527\u2013537", "journal-title": "Leuk Lymphoma"}, {"issue": "12", "key": "9_CR70", "first-page": "1147", "volume": "25", "author": "J Yahalom", "year": "2011", "unstructured": "Yahalom J (2011) Patients with H pylori-independent MALT lymphoma are curable with radiotherapy. Oncology 25(12):1147\u20131149", "journal-title": "Oncology"}, {"key": "9_CR71", "author": "A Wirth", "year": "2013", "unstructured": "Wirth A, Gospodarowicz M, Aleman BM, Bressel M, Ng A, Chao M et al (2013) Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, international extranodal Lymphoma study group study. Ann Oncol. doi:\n                  10.1093/annonc/mds623", "journal-title": "Ann Oncol", "DOI": "10.1093/annonc/mds623", "doi-asserted-by": "publisher"}, {"issue": "16", "key": "9_CR72", "doi-asserted-by": "publisher", "first-page": "3815", "DOI": "10.1002/cncr.25226", "volume": "116", "author": "JS Goda", "year": "2010", "unstructured": "Goda JS, Gospodarowicz M, Pintilie M, Wells W, Hodgson DC, Sun A et al (2010) Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer 116(16):3815\u20133824. doi:\n                  10.1002/cncr.25226", "journal-title": "Cancer"}, {"issue": "1", "key": "9_CR73", "doi-asserted-by": "crossref", "first-page": "10", "DOI": "10.1002/hon.743", "volume": "23", "author": "RW Tsang", "year": "2005", "unstructured": "Tsang RW, Gospodarowicz MK (2005) Radiation therapy for localized low-grade non-Hodgkin\u2019s lymphomas. Hematol Oncol 23(1):10\u201317", "journal-title": "Hematol Oncol"}, {"issue": "28", "key": "9_CR74", "doi-asserted-by": "crossref", "first-page": "7050", "DOI": "10.1200/JCO.2005.04.031", "volume": "23", "author": "P Koch", "year": "2005", "unstructured": "Koch P, Probst A, Berdel WE, Willich NA, Reinartz G, Brockmann J et al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 23(28):7050\u20137059", "journal-title": "J Clin Oncol"}, {"issue": "22", "key": "9_CR75", "doi-asserted-by": "crossref", "first-page": "4157", "DOI": "10.1200/JCO.2003.06.085", "volume": "21", "author": "RW Tsang", "year": "2003", "unstructured": "Tsang RW, Gospodarowicz MK, Pintilie M, Wells W, Hodgson DC, Sun A et al (2003) Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21(22):4157\u20134164", "journal-title": "J Clin Oncol"}, {"issue": "4", "key": "9_CR76", "doi-asserted-by": "crossref", "first-page": "1058", "DOI": "10.1016/S0360-3016(01)02714-6", "volume": "52", "author": "S Hitchcock", "year": "2002", "unstructured": "Hitchcock S, Ng AK, Fisher DC, Silver B, Bernardo MP, Dorfman DM et al (2002) Treatment outcome of mucosa-associated lymphoid tissue/marginal zone non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys 52(4):1058\u20131066", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "3", "key": "9_CR77", "doi-asserted-by": "crossref", "first-page": "657", "DOI": "10.1016/S0360-3016(01)02729-8", "volume": "52", "author": "QT Le", "year": "2002", "unstructured": "Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, Donaldson SS et al (2002) Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52(3):657\u2013663", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "3", "key": "9_CR78", "first-page": "316", "volume": "26", "author": "SM Ansell", "year": "1999", "unstructured": "Ansell SM, Grant CS, Habermann TM (1999) Primary thyroid lymphoma. Semin Oncol 26(3):316\u2013323", "journal-title": "Semin Oncol"}, {"issue": "3", "key": "9_CR79", "first-page": "357", "volume": "26", "author": "E Brogi", "year": "1999", "unstructured": "Brogi E, Harris NL (1999) Lymphomas of the breast: pathology and clinical behavior. Semin Oncol 26(3):357\u2013364", "journal-title": "Semin Oncol"}, {"issue": "1", "key": "9_CR80", "doi-asserted-by": "crossref", "first-page": "67", "DOI": "10.1097/00000421-200102000-00012", "volume": "24", "author": "M Agulnik", "year": "2001", "unstructured": "Agulnik M, Tsang R, Baker MA, Kazdan MS, Fernandes B (2001) Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case report and review of literature. Am J Clin Oncol 24(1):67\u201370", "journal-title": "Am J Clin Oncol"}, {"issue": "3\u20134", "key": "9_CR81", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.3109/10428190109058003", "volume": "41", "author": "S Jhavar", "year": "2001", "unstructured": "Jhavar S, Agarwal JP, Naresh KN, Shrivastava SK, Borges AM, Dinshaw KA (2001) Primary extranodal mucosa associated lymphoid tissue (MALT) lymphoma of the prostate. Leuk Lymphoma 41(3\u20134):445\u2013449", "journal-title": "Leuk Lymphoma"}, {"issue": "2", "key": "9_CR82", "doi-asserted-by": "crossref", "first-page": "224", "DOI": "10.1001/archotol.126.2.224", "volume": "126", "author": "BH Suchy", "year": "2000", "unstructured": "Suchy BH, Wolf SR (2000) Bilateral mucosa-associated lymphoid tissue lymphoma of the parotid gland. Arch Otolaryngol Head Neck Surg 126(2):224\u2013226", "journal-title": "Arch Otolaryngol Head Neck Surg"}, {"issue": "5", "key": "9_CR83", "doi-asserted-by": "publisher", "first-page": "1425", "DOI": "10.1016/j.ijrobp.2007.12.007", "volume": "71", "author": "DR Puri", "year": "2008", "unstructured": "Puri DR, Tereffe W, Yahalom J (2008) Low-dose and limited-volume radiotherapy alone for primary dural marginal zone lymphoma: treatment approach and review of published data. Int J Radiat Oncol Biol Phys 71(5):1425\u20131435. doi:\n                  10.1016/j.ijrobp.2007.12.007", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"issue": "6", "key": "9_CR84", "doi-asserted-by": "publisher", "first-page": "1208", "DOI": "10.3109/10428194.2012.741232", "volume": "54", "author": "SA Milgrom", "year": "2013", "unstructured": "Milgrom SA, Yahalom J (2013) Indolent non-Hodgkin lymphoma primarily involving the hard palate: outcome following radiotherapy. Leuk Lymphoma 54(6):1208\u20131211. doi:\n                  10.3109/10428194.2012.741232", "journal-title": "Leuk Lymphoma"}, {"key": "9_CR85", "unstructured": "NCCN National Comprehensive Cancer Network Guidelines (2013) V.2.2013\u2014Non-Hodgkin\u2019s lymphoma. \n                  http://www.nccn.org/professionals/physician_gls/PDF/nhl.pdf\n                  \n                . Accessed 11 Nov 2013"}, {"issue": "3", "key": "9_CR86", "first-page": "B100", "volume": "80", "author": "J Yahalom", "year": "2001", "unstructured": "Yahalom J (2001) MALT lymphomas: a radiation oncology viewpoint. Ann Hematol 80(3):B100\u2013B105", "journal-title": "Ann Hematol"}, {"key": "9_CR87", "unstructured": "Jager G, Hofler G, Linkesch W, Neumeister P (2004) Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature. Haematologica 89(4):ECR01"}, {"issue": "10", "key": "9_CR88", "doi-asserted-by": "crossref", "first-page": "2190", "DOI": "10.1002/cncr.20237", "volume": "100", "author": "PL Zinzani", "year": "2004", "unstructured": "Zinzani PL, Stefoni V, Musuraca G, Tani M, Alinari L, Gabriele A et al (2004) Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100(10):2190\u20132194", "journal-title": "Cancer"}, {"issue": "8", "key": "9_CR89", "doi-asserted-by": "crossref", "first-page": "2741", "DOI": "10.1182/blood-2002-11-3496", "volume": "102", "author": "A Conconi", "year": "2003", "unstructured": "Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F et al (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102(8):2741\u20132745", "journal-title": "Blood"}, {"issue": "9", "key": "9_CR90", "doi-asserted-by": "crossref", "first-page": "1979", "DOI": "10.1200/JCO.2005.08.128", "volume": "23", "author": "G Martinelli", "year": "2005", "unstructured": "Martinelli G, Laszlo D, Ferreri AJ, Pruneri G, Ponzoni M, Conconi A et al (2005) Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s Lymphoma resistant to or not eligible for anti-helicobacter pylori therapy. J Clin Oncol 23(9):1979\u20131983", "journal-title": "J Clin Oncol"}, {"issue": "S1", "key": "9_CR91", "first-page": "97", "volume": "31", "author": "E Zucca", "year": "2013", "unstructured": "Zucca E, Conconi A, Martinelli G, Tucci A, Vitolo U, Russo E et al (2013) Chlorambucil plus rituximab produces better event-free and progression-free survival in comparison with chlorambucil or rituximab alone in extranodal marginal zone B-cell lymphoma (MALT lymphoma): results of the IELSG-19 study. Hematol Oncol 31(S1):97\u201398", "journal-title": "Hematol Oncol"}, {"issue": "5", "key": "9_CR92", "doi-asserted-by": "publisher", "first-page": "565", "DOI": "10.1200/JCO.2011.40.6272", "volume": "31", "author": "E Zucca", "year": "2013", "unstructured": "Zucca E, Conconi A, Laszlo D, Lopez-Guillermo A, Bouabdallah R, Coiffier B et al (2013) Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patients with extranodal marginal-zone B-cell lymphoma: 5-year analysis of the IELSG-19 Randomized Study. J Clin Oncol 31(5):565\u2013572. doi:\n                  10.1200/JCO.2011.40.6272", "journal-title": "J Clin Oncol"}, {"key": "9_CR93", "unstructured": "Salar A, Domingo-Domenech E, Panizo C, Nicolas C, Bargay J, A. M et al. (2013) Bendamustine plus rituximab in first line systemic treatment for extranodal MALT lymphoma: final results of phase II trial of the Spanish lymphoma study group (GELTAMO). Hematol oncol 31(S1):129\u2013130"}, {"issue": "6", "key": "9_CR94", "doi-asserted-by": "publisher", "first-page": "741", "DOI": "10.1111/j.1365-2141.2009.07677.x", "volume": "145", "author": "JR Brown", "year": "2009", "unstructured": "Brown JR, Friedberg JW, Feng Y, Scofield S, Phillips K, Dal Cin P et al (2009) A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas. Br J Haematol 145(6):741\u2013748. doi:\n                  10.1111/j.1365-2141.2009.07677.x", "journal-title": "Br J Haematol"}, {"key": "9_CR95", "unstructured": "Thieblemont C (2005) Clinical presentation and management of marginal zone lymphomas. Hematology (Am Soc Hematol Educ Program) 2005:307\u2013313", "DOI": "10.1182/asheducation-2005.1.307", "doi-asserted-by": "crossref"}, {"issue": "8", "key": "9_CR96", "doi-asserted-by": "publisher", "first-page": "1350", "DOI": "10.1182/blood-2013-02-486522", "volume": "122", "author": "B Kiesewetter", "year": "2013", "unstructured": "Kiesewetter B, Raderer M (2013) Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood 122(8):1350\u20131357. doi:\n                  10.1182/blood-2013-02-486522", "journal-title": "Blood"}, {"issue": "3", "key": "9_CR97", "doi-asserted-by": "crossref", "first-page": "187", "DOI": "10.1034/j.1600-0609.2002.01649.x", "volume": "68", "author": "J Bosch van den", "year": "2002", "unstructured": "van den Bosch J, Kropman RF, Blok P, Wijermans PW (2002) Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pylori. Eur J Haematol 68(3):187\u2013188", "journal-title": "Eur J Haematol"}, {"issue": "1", "key": "9_CR98", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1136/gut.46.1.133", "volume": "46", "author": "M Raderer", "year": "2000", "unstructured": "Raderer M, Pfeffel F, Pohl G, Mannhalter C, Valencak J, Chott A (2000) Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut 46(1):133\u2013135", "journal-title": "Gut"}, {"issue": "5", "key": "9_CR99", "doi-asserted-by": "crossref", "first-page": "790", "DOI": "10.1046/j.1365-2141.2003.04170.x", "volume": "120", "author": "N Arima", "year": "2003", "unstructured": "Arima N, Tsudo M (2003) Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Haematol 120(5):790\u2013792", "journal-title": "Br J Haematol"}, {"issue": "9", "key": "9_CR100", "doi-asserted-by": "publisher", "first-page": "1370", "DOI": "10.1200/JCO.2005.02.9025", "volume": "24", "author": "B Grunberger", "year": "2006", "unstructured": "Grunberger B, Wohrer S, Streubel B, Formanek M, Petkov V, Puespoek A et al (2006) Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 24(9):1370\u20131375. doi:\n                  10.1200/JCO.2005.02.9025", "journal-title": "J Clin Oncol"}, {"key": "9_CR101", "unstructured": "Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Giordano Resti A, Mazzi B et al. (2005) Regression of ocular adnexal lymphoma following Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 23:5067\u20135073", "DOI": "10.1200/JCO.2005.07.083", "doi-asserted-by": "crossref"}, {"issue": "19", "key": "9_CR102", "doi-asserted-by": "crossref", "first-page": "1375", "DOI": "10.1093/jnci/djj373", "volume": "98", "author": "AJ Ferreri", "year": "2006", "unstructured": "Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S et al (2006) Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J Natl Cancer Inst 98(19):1375\u20131382", "journal-title": "J Natl Cancer Inst"}, {"issue": "5", "key": "9_CR103", "doi-asserted-by": "publisher", "first-page": "1199", "DOI": "10.1111/j.1349-7006.2010.01502.x", "volume": "101", "author": "TM Kim", "year": "2010", "unstructured": "Kim TM, Kim KH, Lee MJ, Jeon YK, Lee SH, Kim DW et al (2010) First-line therapy with doxycycline in ocular adnexal mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of clinical predictors. Cancer Sci 101(5):1199\u20131203. doi:\n                  10.1111/j.1349-7006.2010.01502.x", "journal-title": "Cancer Sci"}, {"key": "9_CR104", "author": "M Troch", "year": "2011", "unstructured": "Troch M, Kiesewetter B, Raderer M (2011) Recent developments in nongastric mucosa-associated Lymphoid Tissue Lymphoma. Curr Hematol Malignancy Rep. doi:\n                  10.1007/s11899-011-0095-9", "journal-title": "Curr Hematol Malignancy Rep", "DOI": "10.1007/s11899-011-0095-9", "doi-asserted-by": "publisher"}, {"issue": "7", "key": "9_CR105", "doi-asserted-by": "publisher", "first-page": "1463", "DOI": "10.3109/10428194.2013.845884", "volume": "55", "author": "C Kalpadakis", "year": "2014", "unstructured": "Kalpadakis C, Pangalis GA, Vassilakopoulos TP, Sachanas S, Angelopoulou MK (2014) Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned? Leuk Lymphoma 55(7):1463\u20131470. doi:\n                  10.3109/10428194.2013.845884", "journal-title": "Leuk Lymphoma"}, {"issue": "2", "key": "9_CR106", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1053/j.seminhematol.2010.01.004", "volume": "47", "author": "M Bennett", "year": "2010", "unstructured": "Bennett M, Schechter GP (2010) Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Semin Hematol 47(2):143\u2013147. doi:\n                  10.1053/j.seminhematol.2010.01.004", "journal-title": "Semin Hematol"}, {"issue": "3", "key": "9_CR107", "doi-asserted-by": "publisher", "first-page": "322", "DOI": "10.1111/bjh.12036", "volume": "159", "author": "M Else", "year": "2012", "unstructured": "Else M, Marin-Niebla A, de la Cruz F, Batty P, Rios E, Dearden CE et al (2012) Rituximab, used alone or in combination, is superior to other treatment modalities in splenic marginal zone lymphoma. Br J Haematol 159(3):322\u2013328. doi:\n                  10.1111/bjh.12036", "journal-title": "Br J Haematol"}, {"issue": "2", "key": "9_CR108", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1634/theoncologist.2012-0251", "volume": "18", "author": "C Kalpadakis", "year": "2013", "unstructured": "Kalpadakis C, Pangalis GA, Angelopoulou MK, Sachanas S, Kontopidou FN, Yiakoumis X et al (2013) Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy. Oncologist 18(2):190\u2013197. doi:\n                  10.1634/theoncologist.2012-0251", "journal-title": "Oncologist"}, {"issue": "3", "key": "9_CR109", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1007/s00277-013-1900-4", "volume": "93", "author": "AJ Olszewski", "year": "2014", "unstructured": "Olszewski AJ, Ali S (2014) Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma. Ann Hematol 93(3):449\u2013458. doi:\n                  10.1007/s00277-013-1900-4", "journal-title": "Ann Hematol"}, {"issue": "3", "key": "9_CR110", "doi-asserted-by": "crossref", "first-page": "468", "DOI": "10.1200/JCO.2005.06.008", "volume": "23", "author": "D Vallisa", "year": "2005", "unstructured": "Vallisa D, Bernuzzi P, Arcaini L, Sacchi S, Callea V, Marasca R et al (2005) Role of Anti-Hepatitis C Virus (HCV) treatment in HCV-related, low-grade, B-Cell, Non-Hodgkin\u2019s Lymphoma: a multicenter Italian experience. J Clin Oncol 23(3):468\u2013473", "journal-title": "J Clin Oncol"}, {"key": "9_CR111", "unstructured": "Arcaini L, Vallisa D, Rattotti S, Ferretti VV, Ferreri AJ, Bernuzzi P et al. (2014) Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol mdu166. doi:\n                  10.1093/annonc/mdu166", "DOI": "10.1093/annonc/mdu166", "doi-asserted-by": "publisher"}, {"issue": "20", "key": "9_CR112", "doi-asserted-by": "publisher", "first-page": "1907", "DOI": "10.1056/NEJMra1213651", "volume": "368", "author": "TJ Liang", "year": "2013", "unstructured": "Liang TJ, Ghany MG (2013) Current and future therapies for hepatitis C virus infection. N Engl J Med 368(20):1907\u20131917. doi:\n                  10.1056/NEJMra1213651", "journal-title": "N Engl J Med"}, {"issue": "21", "key": "9_CR113", "doi-asserted-by": "publisher", "first-page": "2043", "DOI": "10.1056/NEJMe1403619", "volume": "370", "author": "TJ Liang", "year": "2014", "unstructured": "Liang TJ, Ghany MG (2014) Therapy of hepatitis C\u2013back to the future. N Engl J Med 370(21):2043\u20132047. doi:\n                  10.1056/NEJMe1403619", "journal-title": "N Engl J Med"}, {"issue": "2", "key": "9_CR114", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1111/j.1365-2141.2006.06437.x", "volume": "136", "author": "L Arcaini", "year": "2007", "unstructured": "Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F et al (2007) Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol 136(2):301\u2013304. doi:\n                  10.1111/j.1365-2141.2006.06437.x", "journal-title": "Br J Haematol"}, {"issue": "2", "key": "9_CR115", "doi-asserted-by": "publisher", "first-page": "162", "DOI": "10.1111/j.1365-2559.2005.02309.x", "volume": "48", "author": "A Traverse-Glehen", "year": "2006", "unstructured": "Traverse-Glehen A, Felman P, Callet-Bauchu E, Gazzo S, Baseggio L, Bryon PA et al (2006) A clinicopathological study of nodal marginal zone B-cell lymphoma. A report on 21 cases. Histopathology 48(2):162\u2013173. doi:\n                  10.1111/j.1365-2559.2005.02309.x", "journal-title": "Histopathology"}], "container-title": ["Non-Hodgkin Lymphoma", "Cancer Treatment and Research"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/978-3-319-13150-4_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 29]], "date-time": "2019-05-29T07:06:33Z", "timestamp": 1559113593000}, "score": 38.459213, "issued": {"date-parts": [[2015]]}, "ISBN": ["9783319131498", "9783319131504"], "references-count": 115, "URL": "http://dx.doi.org/10.1007/978-3-319-13150-4_9", "relation": {"cites": []}, "ISSN": ["0927-3042"], "issn-type": [{"value": "0927-3042", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:44:05Z", "timestamp": 1574135045094}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1998, 2, 1]], "date-time": "1998-02-01T00:00:00Z", "timestamp": 886291200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[1998, 2]]}, "DOI": "10.1038/sj.leu.2400908", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T18:01:43Z", "timestamp": 1032458503000}, "page": "247-249", "source": "Crossref", "is-referenced-by-count": 14, "title": ["Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach"], "prefix": "10.1038", "volume": "12", "author": [{"given": "E", "family": "Zucca", "sequence": "first", "affiliation": []}, {"given": "F", "family": "Bertoni", "sequence": "additional", "affiliation": []}, {"given": "E", "family": "Roggero", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Cazzaniga", "sequence": "additional", "affiliation": []}, {"given": "G", "family": "Bosshard", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Biondi", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1998, 4, 28]]}, "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2400908.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2400908", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2400908.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T07:01:20Z", "timestamp": 1552719680000}, "score": 37.841408, "issued": {"date-parts": [[1998, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1998, 2]]}, "issue": "2"}, "alternative-id": ["BF2400908"], "URL": "http://dx.doi.org/10.1038/sj.leu.2400908", "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}